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ABSTRACT OF DISSERTATION

ROLE OF SEX CHROMOSOMES IN SEXUAL DIMORPHISM OF ANGIIINDUCED ABDOMINAL AORTIC ANEURYSMS
Abdominal aortic aneurysms (AAAs), a permanent dilation in the
abdominal region of the aorta, is a highly sexually dimorphic disease. AAAs
prevalence is ranging from 4-10 fold higher in males than females. Defining the
mechanistic basis for reduced (in females) or increased (in males) AAA formation
and progression may uncover potential therapeutic targets. The majority of
studies examining sexual dimorphism focus on the role of sex hormones.
However, genes residing on sex chromosomes, in addition to sex hormones,
may contribute to sexual dimorphism of AAAs. For example, the X chromosome
contains about 5% of the whole genome, but the role of sex chromosomes genes
to sexual dimorphism of cardiovascular diseases such as AAAs is largely
unknown. The purpose of this study was to determine the role of sex
chromosomes as mediators of sex differences for angiotensin II (AngII)-induced
AAAs in hypercholesterolemic mice.
We used the four core genotype murine model, which enables the creation
of phenotypically normal male and female mice with an XX versus XY sex
chromosome complement, to test the hypothesis that an XY sex chromosome
complement promotes AngII-induced AAAs. Transgenic male mice expressing the
Sry gene on an autosome, but not on the Y-chromosome, were bred to female
low-density lipoprotein receptor deficient mice to create male and female mice with
an XX or an XY sex chromosome complement.
In females, an XY sex chromosome complement doubled the incidence
and markedly increased the severity of AngII-induced AAAs. To define
mechanisms, we examined gene expression patterns in abdominal aortas and
demonstrated elevated expression of inflammatory genes that were linked to
increased MMP activity and oxidative stress in aortas from XY females.
Moreover, administration of testosterone to XY females, to mimic males, resulted
in a striking level of aneurysm rupture.
In males, transcriptional profiling of abdominal aortas revealed 450 genes
that were influenced by sex chromosomes. Infusion of AngII to XY males resulted
in diffuse pathology along the length of the aorta, while XX males developed
focal AAAs, with pathology reduced by orchiectomy in both genotypes. Thoracic
aortas of XY males exhibited adventitial thickening which was not exist in thoracic

aortas from XX males. Following a prolonged period (3 months) of AngII
infusions XY males had AAAs with expanded aortic walls, while XX males had
thin walled dilated AAAs.
In summary, our findings demonstrate a remarkable effect of sex
chromosome complement to regulate aortic vasculature and disease
development. Aside from demonstrating mechanisms of sexual dimorphism of
aortic diseases, these findings indicate that chronic sex hormone therapy in the
aging and transgender population may have cardiovascular ramifications.
Moreover, identification of targets influenced by sex chromosomes and/or sex
hormones in a manner that predicts disease development may identify sexspecific approaches to cardiovascular therapy.

KEYWORDS: Sexual dimorphism, Sex chromosomes, Testosterone, Abdominal
aortic aneurysm, Angiotensin
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CHAPTER I. INTRODUCTION
1.1

Abdominal Aortic Aneurysms

1.1.1 Background
Abdominal Aortic Aneurysms (AAA) are asymptomatic vascular
diseases with a high mortality rate due to aortic rupture that is manifest in
older adults. AAAs are permanent dilations of the abdominal region of the
aorta, the major blood vessel supplying blood from the heart to all major
organs. In the United States, AAAs are defined as an expansion of the
infrarenal aorta by more than 50% of the normal internal lumen diameter
(Lederle FA, Johnson GR et al. 2000). In Europe, lumen diameter equal or
greater than 3 cm is considered aneurysmal (Ashton HA, Buxton MJ et al.
2002), and because of the high probability of rupture, surgical intervention
is recommended when the diameter reaches a 5.5 cm limit (Powell and
Brady 2004; Jamrozik K et al. 2001). Because no medical treatment has
proven effective against AAA progression, intervention by open or
endovascular surgical repair is the only available option to reduce the
potential for aortic rupture. However, there is still a high mortality rate after
repair (Chang DC, Parine RP et al. 2015; Pecoraro F, Gloekler S et al.
2017). The mean 30-day mortality rate for this surgical procedure is 1.1%7%, which varies among surgical centers and surgeons (Sakalihasan N,
Limet R et al 2005).
Men are more susceptible to AAAs than women. The prevalence of
AAAs is about 1% in women and 4% in men between 50-79 years old, and
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the disease is responsible for 1.3% of all deaths in men aged 65-85
(Lederle FA, Johnson GR et al. 2000; Lederle FA, Johnson GR et al. 2001;
Best VA et al. 2003; Sakalihasan N, Limet R et al. 2005). In the last three
decades, the incidence of AAAs has increased dramatically (Best VA, Price
JF, et al. 2003; Collin J 1988; Fowkes FG, Macintyre CC et al. 1989; Nasim
A, Sayers RD et al. 1995). Compared to data in 1981, AAA mortality rate
and hospital admissions due to AAAs increased by 2.6 fold and 3 fold,
respectively, in 2000, which could be due either to an increase in disease
awareness or to an increase in the aged population, or both (Best VA,
Price JF, et al. 2003). In 1991, in the United States, there was about
16,696 deaths due to a ruptured aortic aneurysm or surgical complication
of aneurysm repair (Gillum 1995). AAAs are estimated to rupture at a rate
of 5.6 cases/ 100,000 people/ year (Bengtsson and Bergqvist, 1993), with
an increased likelihood of AAA rupture as aneurysm size progresses.
According to Lardaro et al, in the Journal of Emergency Medical
Services JEMS, aortic rupture, also they named it as “aortic catastrophe”,
is considered one of the five most common causes of sudden unexpected
death and urge every emergency medical service provider to take this
condition seriously during their early diagnosis of the patient specially if
the patient is old and presented with abdominal or back pain (Thomas
Lardaro, Jared Mckinney et al. 2015). Unfortunately, the risk of death
(85%) is astonishingly high following aneurysmal rupture, and many
patients die before ever reaching the hospital.
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1.1.2 AAA Pathogenesis
AAA is a complex multifactorial disease, and many destructive
factors and cells are involved in damaging the essential components of
the aortic wall (elastin and collagen). The pathophysiology behind the
cellular and molecular mechanisms that are involved in the development
of human AAAs is not well understood. Histologically, AAAs in humans is
characterized by medial degeneration, intensive inflammation, thrombus
formation, break in the elastic media, and remodeling of wall layers
(Busuttil RW et al. 1982; Campa JS, Greenhalgh Rm et al. 1987; Holmes
DR, Liao S et al. 1995). AAA tissue sections exhibit infiltration of
macrophages, T cells, and B cells (Curci JA, Liao S et al. 1998; Galle C,
Schandene L et al. 2005; Xiong W, Zhao Y et al. 2004; Chang TW,
Gracon AS et al. 2015) that secrete degradation factors like proteases
and elastases which degrade the elastic media (loss of elastin leads to
dilation) and collagen (loss of collagen leads to rupture) in the aorta. This
combination of degradation will lead to a decrease in the stretching
strength of the wall allowing dilation and AAA formation (Saraff K et al.
2003, Barisione C, Charnigo R et al. 2006). Indeed, a frequently used
animal model of AAAs targets the elastin in the aortic wall by infusing the
aorta with elastase to induce AAA formation. Further, it has been shown
that a high proteases enzyme activity in the aorta is positively associated
with AAA formation (Alsiraj Y et al. 2017, Halpern VJ et al. 1994). There is
a plethora of evidence that matrix metalloproteinases (MMPs) have a
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principal role in AAA development. Proteinases are usually enriched in
AAA tissue sections (Vine N and Powell JT 1991; Herron GS, Unemori E
et al. 1991; Thompson RW, Holmes DR et al. 1995; Freestone T et al.
1995). Additionally, there is a positive correlation between MMP9
(gelatinase) plasma concentration (Lindholt JS et al. 2000), gelatinase
mRNA abundance in the abdominal aorta (McMillan WD, Tamarina NA et
al.1997) and AAA size. Moreover, transgenic mice with genetic deletions
of MMPs exhibit reduced experimental AAA development (Pyo R, Lee JK
et al. 2000, Longo GM et al, 2002). MMP inhibition using the antimicrobial
drug, doxycycline, or chemically modified tetracyclines, which also have
MMP inhibition properties, have been proven effective in reducing
experimental AAAs in most commonly used animal models when given
prior to the initiation of the disease (Petrinec D, Liao S et al. 1996; Curci
JA, Petrinec D et al. 1998; Bigatel DA, Elmore JR et al. 1999; Manning
MW, Daugherty A et al. 2003; Takai S, Jin D et al. 2013). However, MMP
inhibition was not effective in blunting AAA progression when administered
to mice with an established AAA (Xie X, Daugherty A et al. 2012). In
humans, there was no benefit of doxycycline in reducing the growth rate of
small AAAs (Meijer CA, Stijnen T et al. 2013; Baxter BT, Pearce WH, et
al. 2002). In addition to MMPs, proinflammatory markers are also believed
to be involved in AAA formation like interleukin-6, interleukin-1β,
interleukin-17, and C-reactive protein (Kokje VBC, Gabel G et al. 2016;
Takagi H, Watanabe T et al. 2014; Lindberg S, Zarrouk M et al. 2016;
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Badger SA, Soong CV et al 2009; Stather PW, Sidloff DA et al. 2014).
Genetic deletion or antagonism of these cytokines attenuated
experimental AAA formation (Johnston WF, Salmon M et al. 2013; Wei Z,
Wang Y et al. 2014, Nishihara M, Aoki H et al. 2017). Biochemical factors
like cyclooxygenases, prostaglandin E2 and NADPH have also been
implicated in AAA development (Ghoshal S and Loftin CD 2012; Chapple
KS, Parry DJ et al. 2007; Holmes DR, Wester W et al. 1997; Gavrila D, Li
WG et al. 2005).
1.1.3 Risk Factors
There are many risk factors that are positively associated with
AAAs which include age, male sex, cigarette smoking, genetics, ethnicity,
obesity, hyperlipidemia, low high-density lipoprotein, and atherosclerosis
(Derubertis BG, Trocciola SM et al. 2007; Lederle FA, Johnson GR et al.
2000; Kent KC, Zwolak RM et al. 2010). AAA prevalence increases with
age in both sexes (Singh K, Bonaa KH et al. 2001). The risk for AAAs
increases significantly in people above 60 years old, and the prevalence
increases by 2-4% every ten years afterward (Singh K, Bonaa KH et al.
2001).
Smoking is a significant risk factor for AAA formation. Studies found
that smokers have 7 fold greater risk for AAA development than nonsmokers (Benson RA, Poole R et al. 2016; Norman PE and Curci JA
2013). There is a direct correlation between the number of smoking years
and AAA formation and that risk decreases after smoking discontinuation
5

(Norman PE and Curci JA 2013). Although males and females have a
similar association between smoking and AAAs development the decline
in the risk after smoking cessation is faster in females than males (Kent
KC, Zwolak RM et al. 2010; Lederle FA, Johnson GR et al. 2001;
Stackelberg O, Björck M et al. 2014). Smoking also affects the AAA
endovascular surgical repair as smokers need more stents and they have
a higher risk of stent graft migration than non-smokers (Koole D, Moll FL
et al. 2012).
Aside from age, male sex, and smoking, AAAs are at a higher
prevalence in Caucasians compared to other races (Benson RA, Poole R
et al. 2016; Kent KC, Zwolak RM et al. 2010). Genetic inheritance also
increases AAA risk, as AAA prevalence is very high in siblings of AAA patients,
especially male siblings they have about 4 fold increased risk for AAAs,
and they develop AAAs at an earlier age than people with no family history
and it is recommended to start screening the male siblings of patients with
AAA at a younger age than males with no family history (Linné A,
Lindström D et al. 2012; Salo JA et al. 1999; Linné A, Forsberg J et al.
2016; Linné A, Forsberg J et al. 2017). Obesity has similarly been found to have
a positive correlation with AAA formation (Stackelberg O, Björck M
et al. 2013; Cronin O, Walker PJ et al. 2013). In contrast, diabetes mellitus
has a negative correlation with AAA development (Pafili K, GouniBerthold I et al. 2015; Lederle FA, Johnson GR et al. 2000; Le MT,
Jamrozik K et al. 2007; Theivacumar NS, Stephenson MA et al. 2014).
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Several studies have found no association between the serum
concentrations of cholesterol, triglyceride, and low-density lipoprotein and
AAA development (Blanchard, Armenian et al, 2000; Golledge J, van
Bockxmeer F et al 2010). However, other studies have reported that
hyperlipidemia, ischemic heart diseases, and high blood pressure are
independently associated with AAAs (Törnwall ME, Virtamo J et al 2001;
Derubertis BG, Trocciola SM et al 2007; Kent KC, Zwolak RM et al. 2010).
1.2

Sex Differences in AAAs
AAAs are a highly sexually dimorphic disease, with male sex
considered the strongest non-modifiable risk factor (Wanhainen, Bergqvist
et al. 2005; Forsdahl SH, Singh K et al. 2009). The AAA incidence in
males is 4 times higher than females (Lederle FA, Johnson GR et al.
2001; Katz DJ, Stanley JC, et al. 1997). Despite females protection from
AAAs, if females develop an AAA they have higher growth rates, higher
rupture rates, rupture at smaller sizes, and worse prognosis after surgical
repair compared to males (Noel AA, Gloviczki P et al. 2001; Forbes TL,
Lawlor DK et al. 2006; Solberg, Singh et al. 2005; Mofidi R, Goldie VJ et
al. 2007). Importantly, female protection against AAAs is diminished after
menopause (Bengtsson H, Sonesson B et al. 1996), and the surgical
repair for AAA in females is more difficult because AAAs develop at an
older age (Bengtsson H, Sonesson B et al. 1996).
Ultrasound screening for AAA is recommended for males aged 65
to 75 years and especially those with a family history of AAAs and
7

smokers (Hirsch AT, Haskal ZJ et al. 2006). However, because females
have a lower incidence, the Society of Vascular Surgery only recommends
screening for female smokers and those that have a family history of
AAAs (Hannawa K, Eliason et al. 2009; Kent K et al 2004; Derubertis B,
Trocciola EJ et al. 2007).
One potential mechanism of sexual dimorphism of AAAs is
differences in the vascular anatomy between males and females. Due to
size differences, males tend to have larger and stronger aortas than
females, and this results in a divergence in their vessel biomechanical
properties (Ninomiya OH, Tavares Monteiro JA et al. 2015). The same
study also showed that male aortas had a higher failure load and failure
tension than female aortas. Another small study showed that the peak wall
rupture risk was higher in females (Larsson E, Labruto F et al. 2011).
Furthermore, males and females have anatomic differences that result in
different hemodynamics between the two sexes. For example, the
presence of the uterus in females direct the blood to move away from the
iliac and infrarenal aorta and reduce the amount of stress on these
vessels (Taylor WR, Iffrig E et al. 2016). This results in divergence in
oscillatory stress between males and females. In males, due to the
absence of a uterus, there is a high amount of blood circulation that stress
the infrarenal aorta and might activate the inflammatory system in the
endothelium (Taylor WR, Iffrig E et al. 2016).
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While these anatomical differences are known to exist between the
sexes, recent studies have examined whether sex hormone replacement
therapy also influences AAA development. Clinical studies in females
have demonstrated that sex hormone replacement for greater than 5
years decreased the odds ratio of developing an AAA (Lederle FA, Larson
JC et al. 2008). Interestingly, it has been shown that females that reach
their menopause at a younger age have larger AAAs than females that
reach their menopause at an older age (Villard C, Swedenborg J et al.
2011).
1.3

AAAs and The Renin-Angiotensin System
The renin-angiotensin system (RAS) has been implicated in aortic
aneurysms as the chronic subcutaneous infusion of AngII to mice led to
AAA formation (Daugherty A, Cassis LA et al. 2000, Henriques TA et al.
2004; Henriques TA et al 2008, Zhang X et al 2012; Xie X, Daugherty et
al. 2012; Thatcher SE et al. 2014; Thatcher SE et al. 2015; Zhang X et al.
2015; Alsiraj Y et al. 2017). The RAS is a system that consists of multiple
components that are produced in different organs and work in harmony to
regulate blood volume, blood flow, blood pressure, and electrolyte
balance. In this system, angiotensinogen, the main precursor peptide, is
produced in the liver and is cleaved to form angiotensin I in the circulation
by the enzyme renin secreted from the kidney (Matsusaka T, Niimura F et
al. 2012). Angiotensin I is cleaved to form AngII by angiotensin-converting
enzyme (ACE) that is primarily distributed in endothelial cells of the
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pulmonary circulation. AngII increases the production of reactive oxygen
species along with the induction of several other important factors via
angiotensin type 1 receptors (AT1Rs) resulting in vasoconstriction,
endothelial dysfunction, inflammation, increased level of oxidative stress,
as well as migration/proliferation of vascular cells (Rajagopalan S, Kurz S
et al. 1996; Daugherty A and Cassis L1999; Daugherty A, Cassis LA et
al. 2000; Braun-Dullaeus RC, Mann MJ et al. 1999).
Since 1999, in collaboration with Dr. Alan Daugherty at the
University of Kentucky, our laboratory has demonstrated that chronic
infusion of AngII to hypercholesterolemic mice results in reproducible AAA
formation in the suprarenal abdominal aorta (Daugherty A, Cassis LA et al.
2000, Henriques TA et al. 2004; Henriques TA et al. 2008, Zhang X et al.
2012; Xie X, Daugherty et al. 2012; Thatcher SE et al. 2014; Thatcher SE
et al. 2015; Zhang X et al. 2015; Alsiraj Y et al. 2017). The cellular and
molecular consequences in AAAs that produced by AngII infusion are
medial and adventitial macrophage accumulation, medial dissection,
elastin breaks, that lead to lumen expansion, thrombus formation, and
adventitial inflammation (Saraff K, Babamusta F et al. 2003). In
hypercholesterolemic mice, AngII infusions lead to AAAs in more than
75% of the males and 10%-20% of the females (Henriques TA et al. 2004;
Henriques TA et al. 2008; Zhang X et al. 2012). Similarly, in the elastase
perfusion model of AAAs, male rats had larger and more frequent AAAs
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than females when aortic dilation was induced by intraluminal elastase
perfusion (Ailawadi G, Eliason JL et al. 2004).
Our laboratory demonstrated previously that sex hormones,
specifically androgens, are primary contributors to higher AAA
susceptibility in male compared to female mice, as ovariectomy had no
effect on AAA formation while orchiectomy decreased AAA incidence to
the level of females (Henriques TA et al. 2004). Further studies
demonstrated that testosterone is a primary mediator of the high
prevalence of AAAs in male mice by increasing AT1aR mRNA abundance
specifically in the abdominal region of the aorta (Henriques TA et al.
2008; Zhang X et al. 2012).
The RAS, an important contributor to experimental AAAs, display
sex differences in the gene expression of a number of its important
elements (Wang Y, Pringle KG et al. 2012; Maric-Bilkan C and Manigrasso
MB 2012). Interestingly, genes of some of the essential components of this
system, including, prorenin receptor, angiotensin I converting enzyme 2
(ACE2), and angiotensin II type 2 receptor (AT2R) are located on the X
chromosome. However, previous studies concentrated on gonadal
hormones as the primary mediator of sexual dimorphism in the RAS.
The two most important classes of drugs inhibiting the RAS are
ACE inhibitors (ACEi) that are used to block the conversion of angiotensin
I to AngII, and selective AT1R antagonists (also known as ARBs) that
antagonize the binding of AngII to AT1 receptors (Robles NR, Cerezo I et
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al. 2014). These drugs suppress the activity of the RAS. Unfortunately,
probably due to difficulties in obtaining sufficient sample sizes of AAA
patients for large-scale RAS inhibition studies, or because so many AAA
patients are already prescribed inhibitors of the RAS, few studies have
investigated effects of RAS inhibitors on human AAAs. Studies to date
have an inconsistent agreement about the beneficial effect of RAS
inhibition in AAA (Table 1.1). In a nationwide cohort study, administration
of ACEi reduced all-cause mortality in patients with AAAs who had not
undergone endovascular repair (Kristensen KE, Top-Pedersen C et al.
2015). In a population-based case-control study, AAA patients treated with
ACEi had less chance of aortic rupture, and this beneficial effect was not
seen in patients treated with other antihypertensive drugs, surprisingly
including ARBs (although the patient sample size in this group was small)
(Hackam DG et al. 2006). In contrast, retrospective analysis over 25 years
suggested that ARBs reduced the rate of AAA growth while ACEi was not
effective in slowing AAA growth rates (Thompson A, Hafez H 2010). In
another retrospective analysis study over a period of 15 years (from 1995
to 2010) using the data files from 3 medical centers in the USA found no
effect of ACEi or ARBs on AAA enlargement (Lederle FA, Noorbaloochi S
et al. 2015). Surprisingly, a retrospective study in the United Kingdom
reported that ACEi increases AAA expansion (Sweeting MJ, Thompson
SG et al. 2010). Most recently, a randomized placebo-controlled trial
conducted in 14 hospitals in England found no significant effect of
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perindopril, an ACEi, on the growth rates of small AAAs when
compared to AAA patients who received placebo or a calcium
channel blocker (Bicknell CD, Kiru G et al. 2016).
In standard AAA animal models, modulation of the RAS
components pharmacologically or genetically influences AAA formation
(table 1.2). Deletion of AT1aR inhibited AAA formation in AngII-infused
male mice (Cassis LA, Rateri DL et al. 2007) and in aortic elastaseperfused male mice (Xuan H, Dalman RL et al. 2017). Drug antagonism of
AT1R completely inhibited AAA formation in AngII-infused male mice
(Daugherty A, Cassis LA et al. 2001) and in aortic elastase-perfused male
mice (Iida Y, Xu B, Dalman RL et al. 2012; Xuan H, Dalman RL et al. 2017),
while drug antagonism of AT2R increased the severity of AngII-induced
AAAs (Daugherty A, Cassis LA et al. 2001). Furthermore, Liao et al.
reported that ACEi blunted the development of AAA in elastase-perfused
rats (Liao S, Miralles M et al. 2001). Moreover, administration of aliskiren, a
direct renin inhibitor, to ApoE-/- mice limited the progression of AngIIinduced AAAs (Seto SW, Krishna SM et al. 2014). Additionally,
pharmacological activation of ACE2 reduced internal and external aortic
diameters as well as decreased the incidence of AngII-induced AAAs in
male mice (Thatcher SE, Zhang X et al. 2014) and ACE2 deletion resulted
in increased aortic diameter and AAA incidence in AngII-infused male mice
(Moran CS, Biros E et al. 2017). These results illustrate that RAS blockade
is effective at inhibiting the formation of experimental AAAs, but there is
insufficient evidence supporting a role for RAS blockade in human AAAs.
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Perhaps these differences arise from the heavy focus on the role of
the RAS in AAA formation in experimental studies, versus a need to
develop therapies blunting progression of an established AAA in
humans.
1.4

Role of Sex Hormones and Sex Chromosomes in AAAs
Both human and rodent males are much more susceptible to AAAs
than females. Males are known to differ from females in three ways: sex
chromosomes, sex organs, and sex hormones. These three produce
multiple phenotypic differences between males and females. Sex
chromosomes determine the sex of the fetus. Male and female sex organs
produce different sex hormones that generate the main differences
between the two sexes.

1.4.1 Sex Hormones
In males, testosterone is the main androgen that is important for
many essential physiological functions. Testosterone is responsible for the
development and maintenance of testes, sexual drive, secondary sex
characteristics, sperm production, sexual behavior, bone density, muscle
growth and strength (Murashima A, Kishigami S et al. 2015; Carson JA
and Manolagas SC 2015; Windahl SH, Andersson N et al. 2011).
Testosterone is synthesized in the Leydig cells of the testes, and its
production is regulated by the hypothalamic-pituitary axis, this axis
secretes hormones like a gonadotropin-releasing hormone, luteinizing
hormone, and follicular stimulating hormones in response to the low level
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of testosterone (Tremblay JJ 2015, Potter SJ, Kumar DL et al. 2016). By
the action of the enzyme 5α-reductase, small portion of circulating
testosterone is converted to the more active form, dihydrotestosterone
(DHT). Both testosterone and DHT are binding to androgen receptors
(AR). Unlike testosterone, DHT strongly binds to the AR and slowly
dissociates from the receptor. That is why DHT has a more augmented
action than testosterone (Tóth M and Zakár T 1982; Zakár T, Kaufmann G
et al. 1986; Lemus AE, Enríquez J et al. 1997). Testosterone also gets
converted to estradiol by aromatization through the action of the enzyme
aromatase (Ishikawa T, Glidewell-Kenney C et al. 2006).
In females, the main sex hormones are estrogens, which are a
group of steroid hormones that have an important role in female sexual
functions. Estradiol is the main estrogen; it is synthesized mainly in the
ovary, but estrogens are also produced by the adrenal glands and adipose
tissues. Estrogens act by interacting with estrogen receptors (ER alpha or
ER beta) (Eyster KM 2016; Fietz D et al. 2014, Walter et al. 1985,
Mosselman et al. 1996, Nelsson S and Gustafsson JA 2011).
Many studies on the sexual dimorphism of AAAs have focused on
sex hormones (table 1.3). It has been shown that testosterone is a primary
mediator for the development of AAAs in both male and female rodents
(Henriques T et al. 2004; Zhang X et al. 2015; Zhang X et al. 2012; Davis
J, Salmon M et al. 2016; Cho BS, Woodrum DT et al. 2009; Alsiraj Y et al.
2017). Orchiectomy reduced AngII-induced AAA formation (Henriques TA
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et al. 2004; Henriques TA et al. 2008, Alsiraj Y et al. 2017) and progression
in male mice (Zhang X et al. 2015), and orchiectomy also reduced AAA
formation in aortic elastase perfused male rats (Cho BS, Upchurch GR et
al. 2009). Furthermore, androgen deletion inhibited AAA formation in both
AngII and elastase-induced AAAs of male mice (Huang CK, Chang C et al.
2015; Davis JP, Upchurch GR et al. 2016). Additionally, blockade of
androgen receptors reduces AAA formation in elastase perfused male mice
(Davis JP, Upchurch GR et al. 2016). In one study, using the AngII-infusion
model, it was shown that testosterone increases the expression of AT1aR
in abdominal aortas of male mice, and further, this correlated positively
with AAA incidence (Henriques T et al. 2008). It has also been shown that
exposure of neonatal female mice to a single dose of testosterone
increased AT1aR mRNA abundance in abdominal aortas and AAA
incidence of adult females (Zhang X et al. 2012; Alsiraj Y et al. 2017).
Besides increasing the expression of AT1aR, androgen effects on AAAs
have also been attributed to increased oxidative stress (Chignalia A et al.
2012; Alsiraj Y et al. 2017), inflammation (Razmara A et al. 2005; Sinha I et
al. 2006), and augmented MMP activity (Woodrum D et al. 2005; Laser A
et al. 2014; Alsiraj Y et al. 2017).
In contrast to testosterone, multiple studies have shown that
estrogen has a protective effect on AAA development and progression in
female and male mice and rats (Martin-McNulty B 2003; Thatcher SE et
al. 2015; Laser A et al. 2014; Grigoryants V et al. 2005, Wu XF, Zhang J
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et al. 2009). Estrogen decreased inflammatory pathways (Sinha I et al.
2006) and MMP activity in rat aortic explants (Woodrum D, Ford JW et
al. 2005). However, our laboratory reported that removal of endogenous
estrogen by ovariectomy had no effect on AngII-induced AAAs in female
mice (Henriques TA et al. 2004). In contrast, orchiectomy of male mice
reduced the formation of AngII-induced AAAs to the level of females
(Henriques TA et al. 2004), with AAA incidence restored to normal levels
by administration of DHT (Henriques T et al. 2008). Similar to our results,
studies in the aortic elastase perfusion model in rats reported a similar
conclusion, removal of testosterone from male rats by orchiectomy
decreased AAAs while removal of estrogen from females by ovariectomy
had no effect on AAAs (Cho BS, Upchurch GR Jr et al. 2009).
1.4.2 Sex Chromosomes
Although testosterone is a primary contributor to sex differences in
AngII-induced AAAs, it is unlikely to be the only causative factor. Previous
studies in our laboratory demonstrated that hypercholesterolemic female
mice administered a single dose of testosterone when they are one day
old resulted in a high increase in AT1aR mRNA abundance in the
abdominal region of the aorta, and substantially increased the
susceptibility to AngII-induced AAA when they are adults (Zhang X et al.
2012). Interestingly, the neonatal testosterone effect was permanent and
did not necessitate continued exposure to testosterone. Surprisingly, male
and female mice reacted differently to the administration of neonatal
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testosterone. The same dose of testosterone administered to one-day old
males didn’t change the susceptibility of adult males to AngII-induced AAA
development. Moreover, continuous levels of circulating testosterone are
required in males to maintain AAA susceptibility (Zhang X et al. 2012), while
females were rendered susceptible after a single androgen exposure.
In addition to sex hormones, sex chromosomes have been
suggested to contribute to sexual dimorphism of cardiovascular diseases
(Winham SJ, de Andade M et al. 2015). Probably the most compelling
association between sex chromosomes and vascular disease
development is in Turner’s Syndrome, also called monosomy X. Turner’s
Syndrome results from the partial or complete absence of the second X
chromosome in females, and is associated with significant vascular
abnormalities. Specifically, the risk of aortic dissection is increased 100fold in patients with Turner’s Syndrome (Wong SC et al. 2014; Bondy CA
2008). Moreover, recent studies revealed that sex chromosome
complement affects the blood pressure in AngII infused mice (Ji H, Zheng
W et al. 2010), which could indicate that other AngII-mediated effects may
also be influenced by sex chromosome complement.
Each cell in the human body has a sex, cells carry the genetic
information in 23 pairs of chromosomes that are structured of nucleic
acids and proteins. One pair of which, because they are related to sex, is
called the sex chromosomes while the rest are called autosomes. The
autosome pairs are named by numbers from 1 to 22 while the sex
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chromosomes are named as X and Y. Male cells have a pair of X and Y
while female cells have a pair of two X chromosomes (Buchholz JT 1947;
Mirsky AE and Ris H 1951). The male and female reproductive cells,
sperm and ovum respectively, are haploid cells and contain only one copy
of sex chromosome, the sperm has either the X or the Y chromosome
while the ovum has only X chromosome (Munger SC and Capel B, 2012).
During reproduction, sperm and ovum combine together to produce the
zygote. The sex chromosome of the sperm is the only one that will
determine the sex of the fetus; if the sperm that combines with the ovum
contains the Y chromosome then the fetus will be a male, but if the sperm
contains the X chromosome then the fetus will be a female (Munger SC
and Capel B, 2012; Brennan J and Capel B 2004).
There is a small number of genes on the Y chromosome compared
to any other chromosome. This is due to the fact that the Y chromosome
does not recombine normally as the rest of the genome which result in
losing most of its genes during evolution. In fact, other species, like
orthoptera, has lost the entire Y chromosome. (Charlesworth B and
Charlesworth D 2000; Lahn et al. 2001; Bachtrog et al. 2008; Hughes et
al. 2012; Castillo ER, Bidau CJ et al. 2010). The Y chromosome consists
of two regions: the pseudoautosomal region and the male-specific region
of the Y chromosome (MSY). The pseudoautosomal region is the region
at which the Y chromosome exchanges genetic material with the X
chromosome during meiosis (Helena Mangs A and Morris BJ, 2007;
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Dhanoa JK et al. 2016). The MSY, which represent about 95% of the Y
chromosome, consists of the euchromatic and heterochromatic region
(Skaletsky H et al. 2003; Jangravi Z et al. 2013). Most of the Y
chromosome genes have sex functions (Dhanoa JK et al. 2016). The key
gene on the Y chromosome is the Sry (sex determining region on the Y),
this gene is responsible for testes formation (Prokop JW and C.F.
Deschepper CF, 2015). The Sry has also been implicated in the regulation
of some of the RAS genes (Ely D, Boehme S et al. 2011; Araujo FC,
Milsted A et al. 2015). In contrast, the X chromosome is morphologically
larger and contains more genes than the Y chromosome. In fact, the X
chromosome represents about 5 % of the cell genome (Johnson N.A. and
Lachance J. 2012; Warburton PE et al. 2004).
The presence of two X chromosomes in females leads to a higher
gene expression than males, but females inactivate one of the two X
chromosomes by the process of X chromosome inactivation (XCI). This
process is important to create a balance in gene quantity between XX and
XY cells (Lyon MF 1961; Lyon MF 1962; Jeppesen P and Turner BM,
1993; Ines Pinheiro and Edith Heard, 2017). The inactivated X
chromosome remains inactive throughout the lifetime of the cell (Barakat
TS and Gribnau JX 2012). The mechanism of XCI is complex and highly
organized, and the precise mechanism is still unclear. The X chromosome
that is going to be inactivated express long non-coding RNA called Xist
(Pinheiro I and Heard E 2017; Cerase A, Pintacuda G et al. 2015). The
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expressed Xist recruit proteins followed by several epigenetic changes that
result in chromatin modifications. Genes close to the X-inactivation center
are silenced first and the silencing spread along the length of the
chromosome until the whole chromosome is packed and condensed in an
inactive form called a Barr body (Barr ML and Bertram EG 1949; Lyon MF
1961; Chaligné R and Heard E, 2014; Huynh KD, Lee JT 2003; Jeppesen
P and Turner BM, 1993; Ines Pinheiro and Edith Heard, 2017). There are
two types of XCI: random XCI and imprinted XCI. In mice, the X
chromosome undergoes imprinted XCI. Here, the inactivation is selective
where the X chromosome from the paternal side is selected for inactivation
during the early stages of the embryo development (Sado T, Wang Z et al.
2001; Matsui J, Goto Y et al. 2001). However, this paternal X chromosome
is later activated in the development cycle and random XCI occurs, that
means there is no preference for inactivation, either the maternal or the
paternal X chromosome is randomly selected and inactivated (Mak W.,
Nesterova T.B. et al. 2004; Okamoto I, Arnaud D et al. 2005). In humans
and most mammals, the X chromosome is inactivated by the random XCI
(Moreira de Mello JC, de Arajo ES et al. 2010; Clerc P, Avner P. 2006;
Van den Berg IM, Laven JS et al. 2009). However, some of the genes of
the inactive X chromosome are expressed at varying levels (Berletch et al.
2010; Yang F, Babak T et al. 2010; Berletch JB, Yang F et al. 2011; Li N
and Carrel L, 2008). In humans, 15% of female X-linked genes escape
inactivation while in mice only 3% of the genes from inactive X allele are
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expressed (Berletch JB, Yang F et al. 2011). Of interest, several genes of
the RAS components are located on the X chromosome which includes
prorenin receptor, ACE2, and AT2 receptors; the presence of two X
chromosomes in females could result in gene dosage effects between
males and females. This potential difference is supposedly balanced by Xinactivation that inhibits the transcription of one of the two X chromosomes.
However, there are some genes that escape the inactivation. Males have
only one X chromosome, and most of the genes on the X chromosome
have no equivalent on the Y chromosome. Therefore, genes on the X
chromosome, even if recessive in females, will be expressed in males.
An example of an X-linked disease is Turner’s Syndrome, this
disease is associated with a 100-fold increase in the risk of aortic
dissection (Wong SC et al, 2014; Bondy CA 2008). Another disease linked
to the X-chromosome includes cardiac valvular dysplasia (Bernstein JA,
Bernstein D et al. 2011; Ritelli M, Morlino S, Giacopuzzi E et al. 2017).
Cardiac valvular dysplasia are caused by mutations in the FLNA gene on
the X chromosome. This disease is characterized by a thickened heart
valve that does not function normally (Monteleone PL, Fagan LF 1969;
Kyndt F, Gueffet JP, Probst V et al. 2007; Norris RA, Moreno-Rodriguez
R, Wessels A et al. 2010). Unlike females, males, because they have only
one X chromosome that they received from the mother, manifest this
disease even if only one copy of the genes exist. While females need to
have two copies of the genes to cause the condition (Bernstein JA,
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Bernstein D et al. 201; Ritelli M, Morlino S, Giacopuzzi E et al. 2017). In
this way, females that carry the disease can transfer the condition to her
offspring. Males, on the other hand, cannot pass X-linked traits to their
sons since they inherit the Y chromosome only (Meroni G 1993).
A number of diseases have also been linked to the MSY, such as
high incidence of hypertension and heart disease in men (Bloomer LD et
al. 2013; Charchar Fj et al. 2012; Voskarides K et al. 2014). Further data
have shown that the Y chromosome is linked with inheritance of high
blood pressure, the concentrations of total cholesterol and LDL in the
blood as well as the coronary artery disease (Shankar RR, Charchar FJ et
al. 2007; Charchar FJ, Tomaszewski M, Lacka B, et al. 2004; Charchar
FJ, Tomaszewski M, Padmanabhan S, et al. 2002; Ellis JA, Stebbing M,
Harrap SB 2000; Charchar Fj et al. 2012). However, mechanisms for this
association are unknown. Sadly, the sex chromosomes are not included in
the genome-wide association study (GWAS) and the X chromosome
despite being assayed on all GWAS studies only 33% of these studies
included the X chromosome in the analyses (Wise AL, Manolio et al. TA
2013).
1.5 Four Core Genotype Mouse Model
The four core genotype mouse model (FCG), produces mice with
gonadal organs that are independent of their sex chromosome
complement and this allows dissection of the relative role of sex
chromosome complement versus sex hormones. This model has been
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used by multiple investigators and demonstrates that sex chromosome
complement contributes to sexual dimorphism of the brain and other
tissues in mice (Arnold AP and Chen X 2009; De Vries GJ et al. 2002).
Other studies using this model identified that blood pressure responses to
infusion of AngII were influenced by both sex hormones and sex
chromosomes (Ji H, Zheng W et al. 2010). The FCG was generated from a
natural mutation of the gene that is responsible for testes formation, Sry
gene, from the Y chromosome (Lovell-Badge R and Robertson E, 1990;
Mahadevaiah SK, Odorisio T et al. 1998). This mutation resulted in a
mouse that has the XY- (lacking Sry) sex chromosome complement, this
mouse does not develop testes but will develop ovaries instead, making it
a female that has male sex chromosome complement and female gonads.
The insertion of the Sry gene onto an autosome in XY- mouse result in
generating a male mouse that expresses Sry (on an autosome but not on
the Y chromosome) denoted as XY- (+ Sry). The presence of the Sry gene
on an autosome in this mouse lead to the development of testes, allowing
the male to breed normally. When XY-(+ Sry) males are mated with
normal XX females, 4 genotypes are produced (Figure 1.1):
1. XY- females (abbreviated as XYF, have ovaries)
2. XX females (abbreviated as XXF, have ovaries)
3. XY males (abbreviated as XYM, have testes)
4. XX males (abbreviated as XXM, have testes)
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Previous studies using this mouse model indicate that testosterone
concentrations are not different between XY and XX males (Gatewood JD, Wills
A et al. 2006). If there is a difference in a certain phenotype between XX and XY
mice that have the same gonadal phenotype, then the difference is caused by
sex chromosomes. That difference could be due to (a) Gene dosage effects from
the Y chromosome, because XY mice are affected by Y genes while XX mice are
not; (b) Gene dosage effects from the X chromosomes, because XX mice have
two X chromosomes, and for genes that escape X-inactivation there could be
gene dosage effects; (c) Parental origin of the X chromosome, XY mice receive
only maternal X chromosomes while XX mice receive both the paternal and
maternal X chromosomes.
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CHAPTER IA. STATEMENT OF THE PROBLEM
AAA development is significantly different between sexes. Males are
much more susceptible to AAAs than females. Similar to humans, male mice
infused with AngII have a fourfold higher prevalence of AAAs compared to
females. Paradoxically, while females are less susceptible to AAAs, female AAAs
progress more rapidly and rupture at smaller sizes than males. Previous studies
focused on gonadal hormones as primary contributors to sexual dimorphism in
AngII-induced AAAs. Our laboratory previously demonstrated that sex hormones,
specifically testosterone, are primary mediators to marked differences in AngIIinduced AAAs between male and female hypercholesterolemic mice.
Our laboratory recently demonstrated that exposing one-day-old
hypercholesterolemic female mice to a single dose of testosterone resulted in a
high increase in AAA development when adult females were infused with AngII.
Interestingly, female mice become susceptible to AAA formation from only a
single androgen exposure during neonatal life while males require continued
circulating levels of testosterone to stay susceptible to AAA, as gonadectomy
decrease AAAs incidence in males and has no effect in females (Henriques TA
et al. 2004). Results from these studies indicate that while important, gonadal
hormones cannot fully account for the sexual dimorphism of AAA development.
Recent studies indicated that in addition to gonadal hormones, sex
chromosome complement influence the blood pressure in AngII-infused mice (Ji
H, Zheng W et al. 2010). Moreover, several studies showed that the Sry gene
of the Y chromosome regulates the gene expression of some of the RAS
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components (Ely D, Boehme S et al. 2011; Araujo FC, Milsted A et al. 2015). In
fact, several genes of the RAS are X-linked, genes that escape X inactivation
could result in a gene dosage effect. Finally, in human, loss of X chromosome in
females, as in Turner’s syndrome, is associated with a high risk of aortic
dilations and dissections (Wong SC et al. 2014; Bondy CA 2008). We
hypothesize that an XY sex chromosome complement, in addition to sex
hormones, promotes AngII-induced AAAs in hypercholesterolemic mice.
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CHAPTER IB. Hypothesis
Sex chromosome effects, in addition to sex hormones, contribute to the sexual
dimorphism of AngII-induced AAAs.
The following specific aims tested this general working hypothesis:
Specific Aim 1: Determine the role of an XY sex chromosome complement with
and without exogenous androgen in AngII-induced AAAs in hypercholesterolemic
female mice.
Specific Aim 2: Examine the role of an XX sex chromosome complement with
and without the presence of endogenous androgen in AngII-induced AAAs in
hypercholesterolemic male mice.
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Table 1.1: Summary of findings of human AAAs studies using RAS inhibitors
Drug analyzed

Effect on AAA

Reference

ACEI

Reduced risk of ruptured AAA

Hackam DG et al 2006

ACEI

No effect on AAA growth rate

Thompson A et al 2010

ARBs

Reduced the AAA growth rate

Thompson A et al 2010

ACEI

Increased the AAA growth rate

Sweeting MJ et al 2010

ACEI

Reduced the risk of surgery for AAA

Kristensen KE et al 2015

ARBs

Reduction in all-cause mortality

Kristensen KE et al 2015

ACEI

No effect on AAA enlargement

Lederle FA et al 2015

ARBs

No effect on AAA enlargement

Lederle FA et al 2015

ACEI

No effect on AAA growth rate

Bicknell CD et al 2016

ACEI

No effect on AAA growth rate

Kortekaas KE et al 2014
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Table 1.2: Summary of animal AAA studies modulating the RAS
Application

Mouse model

Effect

References

AT1aR deletion

AngII-induced AAA in mice

decrease

Cassis et al 2007

AT1aR deletion

elastase-induced AAA in mice

decrease

Xuan H et al 2017

ACE inhibition

elastase-induced AAA in rats

decrease

Liao S et al 2001

AT1R antagonism

AngII-induced AAA in mice

decrease

Daugherty A et al 2001

AT1R anatagonism

elastase-induced AAA in mice

decrease

Iida Y, Dalman et al 2012

AT1R antagonism

elastase-induced AAA in rats

decrease

Xuan H et al 2017

AT2R antagonism

AngII-induced AAA in mice

increase

Daugherty A et al 2001

Renin inhibition

AngII-induced AAA in mice

decrease

Seto SW et al 2014

ACE2 activation

AngII-induced AAA in mice

decrease

Thatcher SE et al 2014

ACE2 deletion

AngII-induced AAA in mice

increase

Moran CS et al 2017
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Table 1.3: Summary of animal AAA studies modulating sex hormones
Application

model

findings or effect on

Reference

AAA
Estradiol treatment

AngII infused male mice

decrease AAA

Martin-McNulty B,
Tham DM et al 2003

Orchiectomy

AngII infused male mice

decrease AAA

Henriques TA, Cassis
LA et al 2004

Ovariectomy

AngII infused female

no effect

mice

Henriques TA, Cassis
LA et al 2004

male vs females,

elastase perfusion in

M>F, estradiol decrease

Ailawadi G, Upchurch

estradiol treatment

male and female rats

AAA

GR et al 2004

Tamoxifen

elastase perfusion in

decrease AAA

Grigoryants V,

male rats

Upchurch GR et al
2005

Orchiectomy

AngII infused male mice

decrease AAA

Henriques TA, Cassis
LA et al 2008

DHT administration

AngII infused male and

increase AAA

female mice

Henriques TA, Cassis
LA et al 2008

castration, estradiol

elastase perfusion in

treatment

male and female rats

Ovariectomy, estradiol

elastase perfusion in

ovariectomy increase,

Wu XF, Zhang J et al

treatment

female rats

estradiol decrease AAA

2009

Neonatal testosterone

AngII infused female

increase AAA

Zhang X, Cassis LA

administration

mice

Orchiectomy

AngII infused male mice

Ovariectomy

decrease AAA in males

Cho BS Upchurch
GR et al 2009

et al 2012

elastase perfusion in
female mice

decrease progression of

Zhang X, Cassis LA

established AAA

et al 2015

increase AAA

Johnston WF,
Upchurch GR et al
2015
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Table 1.3 continued
Deletion of androgen

AngII infused in male

receptor

mice

Androgen receptor

elastase perfusion in

blockage

male mice

Deletion of androgen

elastase perfusion in

receptor

male mice

Neonatal testosterone

AngII infused female

administration

mice

DHT administration

AngII infused female

decrease AAA

et al 2015
decrease AAA

Davis JP, Upchurch
GR et al 2016

decrease AAA

Davis JP, Upchurch
GR et al 2016

increase AAA

Alsiraj Y, Cassis LA
et al 2017

increase AAA

mice
Orchiectomy

Huang CK, Chang C

Alsiraj Y, Cassis LA
et al 2017

AngII infused male mice

decrease AAA

Alsiraj Y, Cassis LA
et al 2017

Ovariectomy

AngII infused female

no effect

mice

Alsiraj Y, Cassis LA
et al 2017
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Figure 1.1. The four core genotype mouse model. XXF is mated to male mice lacking
Sry on sex chromosomes but expressing Sry on autosomes to create four core
genotypes.

Copyright © Yasir Alsiraj 2018
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CHAPTER II. SPECIFIC AIM 1
Female Mice with an XY Sex Chromosome Complement Develop Severe
Angiotensin II-Induced Abdominal Aortic Aneurysms (Published in the
journal of Circulation)
Authors: Yasir Alsiraj, Sean Thatcher, Richard Charnigo, Kuey Chen, Eric
Blalock, Alan Daugherty, and Lisa Cassis.
Circulation. 2017;135:379-391
URL:http://circ.ahajournals.org/content/135/4/379.full?ijkey=w6Z9bijRtCzO4PR&k
eytype=ref
Summary
Background: Abdominal aortic aneurysms (AAAs) are a deadly pathology with
strong sexual dimorphism. Similar to humans, female mice exhibit far lower
incidences of angiotensin II (AngII)-induced AAAs than males. In addition to sex
hormones, the X and Y sex chromosomes, and their unique complements of
genes, may contribute to sexually dimorphic AAA pathology. Here, we defined the
effect of female (XX) versus male (XY) sex chromosome complement on AngIIinduced AAA formation and rupture in phenotypically female mice.
Methods: Female low density lipoprotein receptor (Ldlr) deficient mice with an
XX or XY sex chromosome complement were infused with AngII for 28 days to
induce AAAs. Abdominal aortic lumen

diameters

were

quantified

by

ultrasound, while AAA diameters were quantified at study endpoint. DNA
microarrays were performed on abdominal aortas. To mimic males, female mice
were administered a single dose of testosterone as neonates or as adults prior to
AngII infusions.
Results: Female Ldlr-/- deficient mice with an XX and XY sex chromosome
complement had similar sex organ weights and low serum testosterone
concentrations. Abdominal aortas from female XY mice selectively expressed Y
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chromosome genes, while genes known to escape X-inactivation were higher in
XX females. The majority of aortic gene differences in XY versus XX females fell
within inflammatory pathways. AAA incidences doubled and aneurysms ruptured
in XY females. AAAs from XY females exhibited inflammation, and plasma IL1β
concentrations were increased in XY females. Moreover, aortas from XY females
had augmented matrix metalloproteinase activity and increased oxidative stress.
Finally, testosterone exposure applied chronically, or as a single bolus at postnatal
day 1, markedly worsened AAA outcomes in XY compared to XX adult females.
Conclusions: An XY sex chromosome complement in phenotypic females
profoundly influenced aortic gene expression profiles and promoted AAA severity.
When XY females were exposed to testosterone, aneurysm rupture rates were
striking. Mechanisms for augmented AAA severity in XY females include
increased inflammation, augmented matrix metalloproteineases and oxidative
stress. Our results demonstrate that genes on the sex chromosomes regulate
aortic vascular biology and contribute to sexual dimorphism of AAAs. Sex
chromosome genes may serve as novel targets for sex-specific AAA therapeutics.
2.1 Introduction
Genes on sex chromosomes have been implicated in inherited forms of
cardiovascular diseases (Charchar, Bloomer et al. 2012, Bloomer, Nelson et al.
2013), but much less is known about the influence of sex chromosomes, and
their interplay with sex hormones, on development of common complex
cardiovascular diseases. Turner’s Syndrome (monosomy X) is associated with
significant risk of aortic dissection (Wong, Burgess et al. 2014), suggesting an
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important role for sex chromosomes in the regulation of aortic homeostasis.
Abdominal aortic aneurysms (AAAs), an insidious vascular disorder without
effective drug therapies, are another example of an aortic disease exhibiting
genetic inheritance (Clifton 1977; Johansen and Koepsell 1986; Blanchard,
Armenian et al. 2000; Rossaak, Hill et al. 2001) and pronounced sexual
dimorphism (Morris, Hubbard et al. 1994; Pleumeekers, Hoes et al. 1994;
Wilmink, Pleumeekers et al. 1998; Weiss, Rodionov et al. 2014). Understanding
the combined influences of sex hormones and chromosomes on aortic vascular
biology and disease may identify novel therapeutic targets that are beneficial for
treatment of vascular diseases in one sex versus the other. Moreover, as chronic
sex hormone therapy is on the rise in aging males and females, as well as in the
transgender population, it is important to increase knowledge regarding sex
hormone and chromosome effects on the vasculature. We demonstrated
previously that AAAs induced in mice by angiotensin II (AngII) infusion exhibit
pronounced sex differences. Similar to humans, there is a 4-fold higher AAA
prevalence in male compared to female mice infused with AngII (Henriques,
Huang et al. 2004). Testosterone was demonstrated as a primary regulator
of the formation and severity of AngII-induced AAAs in male mice (Henriques,
Huang et al. 2004; Henriques, Zhang et al. 2008). However, not all differences
in AAA susceptibility and severity between male and female mice could be
explained by chronic presence of testosterone (Zhang, Thatcher et al. 2012).
Recent studies demonstrated that blood pressure responses to AngII in mice
were influenced by sex chromosomes (Ji, Zheng et al. 2010). Herein, we
embarked on an analysis of effects of an XX versus an XY sex chromosome
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complement on aortic gene expression profiles and on development and
severity of AngII-induced AAAs in phenotypically

female

mice. Gene

expression profiles demonstrated enriched inflammatory genes in abdominal
aortas from XY compared to XX females. When XY females were infused with
AngII, AAA incidences doubled and aneurysms ruptured.
Exposure of XY females to testosterone, to mimic the male sex hormone
environment, led to striking levels of AAA rupture. Our results indicate a previously
unrecognized role for sex chromosomes to influence aortic gene expression
patterns and profoundly affect AAA severity.

2.2 Methods
2.2.1 Animals
Male mice with an XY-Sry genotype {8-12 weeks of age; 10 times
backcrossed on C57BL/6J background, Stock#010905}, were obtained from The
Jackson Laboratories and bred to low density liproprotein receptor deficient
(Ldlr-/-) females (Stock# 002207). Genomic DNA was isolated from tail clips and
subjected to PCR using a commercial PCR mix (Promega 2X Master Mix,
cat#m7123) and specific primers (Table 2.2). DNA fragments were recognized as
350 (mutation) and 200 bp (internal positive control) bands, while XX females
displayed only a 200 bp band. Mice were placed on a high fat diet (TD88137,
Harlan Teklad, Indianapolis, IN) for the duration of the experiment. In mice
administered testosterone as neonates, within 24 hours of birth female mice were
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injected subcutaneously with a single dose of testosterone propionate (400
μg/mouse, n=6-12 mice/genotype; Sigma Aldrich, St. Louis, MO). At 8 weeks of
age, all females were ovariectomized (OVX) to eliminate any potential
confounding influence of female sex hormones (Henriques, Huang et al. 2004).
In mice administered DHT as adults, OVX females (8-12 weeks of age) were
implanted with a dihydrotestosterone (DHT) pellet (10 mg pellets/60 day
sustained release; 0.16 mg/d; n=11-18 mice/genotype) two weeks prior to AngII
infusion and continued through study endpoint (Henriques, Zhang et al. 2008) All
procedures were in accordance with institutional guidelines and were approved
by the animal care and use committee at the University of Kentucky.
2.2.2 Isolation of Bone Marrow Cells
Bone marrow was extracted from the tibias and femurs of XX and XY female
mice (2 months of age; n=3 mice/genotype), and bone marrow cells were
differentiated into macrophages by supplementing the culture media (RPMI
medium, 2% penicillin/ streptomycin, 1% fungizone) with 1 ng/ml of CSF (Colony
Stimulating Factor) for 6 days. Total RNA was extracted using the Rneasy fibrous
tissue mini kit (Qiagen, cat#74704).
2.2.3 Gonadectomy
Female XX and XY Ldlr-/- mice (8-12 weeks of age) were OVX as
described previously (Henriques, Huang et al. 2004). Two weeks later (to clear
endogenous ovarian- derived hormones), mice were infused with AngII.
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2.2.4 AngII Infusions.
Mice were infused with saline or AngII (1,000 ng/kg/min, Bachem,
Torrance, CA) by osmotic micropumps (Alzet model 1004 for 28 day infusions,
Durect Co., Cupertino, CA). At study endpoint, all mice were euthanized using
a ketamine/xylazine mixture (100:10 mg/kg, IP) in sterile saline and blood
collection was performed via cardiac puncture.
2.2.5 Quantification of AAAs by ultrasound, ex-vivo AAA measurements, and 3D
volume analysis.
Internal suprarenal lumen diameters were quantified on day 0, 7, 14, and 28
of AngII infusions using a 55-MHz probe with a Vevo 2100 high-resolution
imaging system (VisualSonics, Inc.). Mice were anesthetized (2-3% isoflurane)
and abdominal hair was removed by shaving and applying a depilatory cream.
Mice were imaged and allowed to recover on a heating pad. Images were
analyzed by two independent observers who were blinded to the study design.
Mice with a 50% increase in abdominal aortic lumen diameter from baseline (day
0) were diagnosed with an AAA, and included in statistical analysis for each
measure if they completed study protocol. External abdominal aortic diameters
were measured at study end point on aortas mounted on a black wax
background. Images were taken using a Nikon SMZ800 dissecting microscope
and image analysis to obtain maximal AAA diameters was performed using
Nikon Elements Version 3.2. AAA incidence was defined as a 50% increase in
abdominal aortic lumen diameter on day 28 of AngII infusions and included mice
that died from aneurysm rupture. Percent of rupture was calculated as the % of
mice within each group that died from a verified rupture of the aorta upon
necropsy. Grading of AAA severity was defined previously (Daugherty, Manning
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et al. 2001). Three-dimensional volume analysis was performed on abdominal
aortas of OVX XY and XX females (n=5 mice/genotype) using the Vevo 2100
system with the 55-MHz probe. Abdominal aortas were scanned at 51μm
intervals and a total of 295 images were collected. Each image was analyzed for
lumen and wall volume and images were summed to obtain total cubic millimeter
volume of abdominal aortas.
2.2.6 Blood pressure measurements.
Systolic blood pressure was measured on conscious mice using a noninvasive computerized tail-cuff system (BP-2000; Visitech Systems, Apex, NC)
during week 3 of AngII infusions. Mice were acclimated to the blood pressure
system for 2 days and measurements were taken over 5 subsequent days.
2.2.7 Measurements of plasma and serum components.
Total serum cholesterol concentrations were quantified using enzymatic
assay kits (Wako Pure Chemical, Richmond, VA, cat#439-17501). Plasma renin
concentrations were determined by quantifying angiotensin I concentrations
generated in the absence or presence of an excess of exogenous rat
angiotensinogen as described previously (Zhang, Thatcher et al. 2012).
Angiotensin I was quantified by radioimmunoassay using a commercial kit
(DiaSorin, CA-1553, Stillwater, MN). Plasma concentrations of IL1β were
quantified using a commercial Quantikine ELISA (R&D Systems, Minneapolis,
MN).
2.2.8 Quantification of atherosclerosis.
Aortas were cleaned, opened longitudinally and mounted on a black wax
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background to quantify atherosclerosis in the aortic arch and thoracic aorta. Arch
and thoracic aorta areas were defined and lesions within this area were summed
and normalized to total region area to calculate the percent intimal surface area
covered by an atherosclerotic lesion. Quantification was performed using Nikon
Elements Version 3.2.
2.2.9 Abdominal aorta RNA extraction
Female (8 weeks of age) XX and XY mice (n=5 mice/surgical
group/genotype) underwent sham surgery or OVX, and two weeks later mice
were fed the Western diet for 1 week. Aortas were cleaned from extraneous
tissues under a dissecting microscope and placed in RNA Later (Ambion,
cat#AM7021). Abdominal aortas (diaphragm to the ileac bifurcation) were used
for RNA extraction. RNA was extracted using the Rneasy fibrous tissue mini kit
(Qiagen, cat#74704), and RNA concentration and quality was quantified by
Agilent 2100 bioanalyzer using RNA 6000 Nano labchip kits (Agilent
Technologies, Cat# 5067-151). Samples with RIN (RNA Integrity Number)
> 8 were used for either DNA microarray or RT-PCR.
2.2.10 DNA microarrays
Harvested

abdominal

aortic

RNA

samples

(n=5

mice/surgical

group/genotype) did not differ significantly among treatment groups (Agilent
Bioanalyzer RNA Integrity Number [RIN]: 9.51 ± 0.07, p= 0.25; [RNA] (ng/ul):
39.5 ± 3.4, p=0.93; 28s:18s ratio: 2.83 ± 0.89, p=0.33- all statistical tests by
ANOVA). Extracted RNA was labeled and hybridized to Affymetrix Mouse
Transcriptome Assay 1.0 arrays (one array per subject). Signal intensities were
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calculated using the RMA algorithm (Bolstad, Irizarry et al. 2003) at the transcript
level using Genomics Suite software (Partek, St Louis). Data were transferred to
flat files in Excel and associated with vendor-provided annotation data. Prestatistical filtering retained unique, annotated probe sets with adequate signal
intensity (signal intensity ≥ 4.2 on at least 4 arrays in the study). Filtered signal
intensities were analyzed by two-way ANOVA to identify significant main effects
of genotype (XX versus XY), surgery (sham vs OVX), as well as interaction. The
False Discovery Rate (FDR) procedure (Hochberg and Benjamini 1990) as
modified by Storey (Storey 2002) was used to control error associated with
multiple testing, with an FDR q- value < 0.05 defining significance. The complete
list of significant results is provided in table 2.3. Functional categorization for
each expression pattern was determined with the prestatistically filtered gene
list as a background using DAVID bioinformatic tools (Huang da, Sherman et
al. 2009). Currently, DAVID does not support Affymetrix MTA 1.0 IDs, and
therefore best match IDs from Affymetrix Mouse 1.0 Exon arrays were used,
covering more than 90% of the filtered MTA data set. Raw data are available
through

the

Gene

Expression

Omnibus

(GSE

#:81580

www.ncbi.nlm.nih.gov/geo/).
2.2.11 Zymography
Female mice (n=4 mice/genotype) were infused with AngII (1,000 ng/kg/
min) for 24 hours, aortic protein (10 μg) was extracted and resolved using SDSPAGE (7.5%) polymerized in the presence of gelatin (2 mg/ml) to detect MMP
activity. Gels were washed with 2.5% Triton X-100 (1 hr) followed by distilled
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water (30 min), and incubated overnight (37°C) in Tris buffer containing 10 mM
calcium chloride and 0.02% sodium azide. Gels were stained with Coomassie
Brilliant Blue for 3 hours and destained using distilled water. Gel images were
captured using a Syngene PXi imager; the unstained, translucent digested
regions represented areas of MMP2 activity.
2.2.12 Quantification of oxidative stress in aortic tissue explants
Aortas (thoracic and abdominal segments) from XX and XY Ldlr-/- females
were cleaned of adherent tissue and placed in culture media (DMEM; 1:1 without
phenol red). Aortic explants were incubated with vehicle (saline) or AngII (10 μM)
plus testosterone (10 nM) for 24 hrs to simulate conditions of high AAA incidence
and severity. Tissues were snap frozen (OCT) in molds for serial tissue sections
(10 μm). Aortic sections were incubated with dihydroethidium (DHE, 10 μmol/L)
in phosphate buffered saline for 30 min (37°C), and counterstained with DAPI.
Images were obtained (100X; 3-5 images/slide) on a Nikon Eclipse microscope
(TE2000-U) with a monochrome camera (exposure=300ms). Histogram plots
were generated for each image using Nikon Elements software, and areas under
the curve for pixel intensities (250-2500) were calculated.
2.2.13 Statistical Analysis
Numerical data are generally illustrated as mean ± SEM and were
analyzed using unpaired t-test or Mann-Whitney tests to compare two groups,
by two-way repeated measures ANOVA on time for longitudinal data with
between group factor of surgery or genotype, or by two-way ANOVA with
between group factors of surgery, treatment (e.g., testosterone in some studies),
or genotype. Brown-Forsythe tests for homogeneity of variance were performed
43

in some cases, which led to the modification of two of the two-way ANOVA’s;
these were modified by weighting observations inversely proportionally to their
within-group variances. The Kaplan-Meier method was used to estimate
survival curves. The incidence of aneurysm formation was analyzed using
Fisher’s exact tests. Statistical analysis was performed using SigmaPlot (Systat
Software Inc., San Jose CA) or SAS (SAS Institute Inc., Cary NC), and statistical
significance was determined at P< 0.05.
2.3 Results
2.3.1 An XY sex chromosome complement promotes expression of
inflammatory genes in abdominal aortas.
To define a role of sex chromosomes in regulating aortic gene expression
profiles, we bred male mice expressing autosomal Sry (the testes determining
gene) to Ldlr deficient females to create XX and XY female offspring (Arnold
and Chen 2009). W e focused on female XX and XY mice to enable definition
of the role of sex chromosomes under experimentally controlled exposures
to testosterone, since testosterone is known to promote AngII-induced AAAs
in male mice (Henriques, Huang et al. 2004). We first determined effects of
sex chromosome complement on gene expression profiles in abdominal aortas
from non-infused (AngII-naïve) XX and XY females in the presence (shamoperated) or absence (OVX) of endogenous female sex hormones. Body
weights were similar between genotypes prior to surgery (data not shown).
Body weights of XX (sham, 22.4 ± 1.0; OVX, 26.8 ± 0.8g; P<0.05), but not of
XY females (sham, 22.6 ± 1.5; OVX, 23.1 ± 0.7g; p=0.75) were increased
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significantly by OVX compared to sham- operated controls. We performed
transcriptome analyses on RNA extracted from abdominal aortas of XX and
XY female mice using Affymetrix Mouse Transcriptome Assay 1.0 arrays. A
total of 88 genes exhibited highly significant differences (two-way ANOVA, FDR
≤ 0.05, Figure 2.1A, Table 2.3). Remarkably, all 88 genes were significant by
the main effect of chromosome only. Volcano plots of the chromosome effect
with highly stringent cutoffs (> 2-fold change, P< 1x10-6) demonstrated that,
as expected, the expression of genes on sex-chromosomes was strongly
influenced. Genes (Ddx3y, Uty, Kdm5d, Eif2s3y) within the male-specific
region of the Y chromosome (MSY) were significantly increased in female
abdominal XY aortas (Figure 2.1B, fold increase in XY). These genes are of
interest as the MSY constitutes approximately 95% of the length of the Y
chromosome (Skaletsky, Kuroda-Kawaguchi et al. 2003), does not recombine
with the X chromosome during meiosis, is inherited from father to son, and
has been linked to cardiovascular risk in humans (Skaletsky, KurodaKawaguchi et al. 2003, Bloomer, Nelson et al. 2013). A second group of
genes (Kdm5c, Eif2s3x, Kdm6a, Ddx3x) known to escape X- inactivation in
mice (Berletch, Yang et al. 2011), were increased in abdominal aortas of XX
females (Figure 2.1B, fold increase in XX). A third group of genes (Msl3,
Tlr7, Tlr8, Prps2, Arhgap6) are X-linked genes, but were increased in
abdominal aortas from XY compared to XX females (Figure 2.1B, fold
increase in XY). Further, genes across multiple chromosomes were strongly
influenced by the presence of the Y chromosome.
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Real-time PCR on abdominal aortas validated selected microarray
results (Kdm5d, Eif2s3y, Xist) for the main effect of an XY sex
chromosome complement (Figure 1C) and verified microarray findings for
genes not exhibiting significant differences between genotypes (GAPDH,
Figure 2.7).

However, mRNA abundance of Uty, a gene on the Y

chromosome, was not significantly different between aortas from shamoperated female XX compared to XY mice, and expression was increased by
OVX in aortas from XY females, but not XX females (Figure 2.1C). Biological
pathway

analyses

(Table

2.1)

revealed

prominent

upregulation

of

inflammatory genes in abdominal aortas from XY females (Figure 2.8).
These

results

demonstrate

that

sex

chromosomes influence

gene

expression profiles of abdominal aortas, with increased expression of
inflammatory pathway gene targets in XY compared to XX. Enrichment of
genes on the Y chromosome in aortas from XY females, coupled with
increased expression of genes known to escape X-inactivation in aortas
from XX females, confirm validity of sex chromosome manipulation in
phenotypically female mice.
2.3.2 An XY sex chromosome complement results in aggressive AAA formation
and severity.
Female (XX) Ldlr-/- mice exhibit far lower incidences (≈ 25-40%) of AngIIinduced AAAs compared to age-matched males (≈ 75-90%) (Henriques, Huang et
al. 2004, Henriques, Zhang et al. 2008). To define the role of sex chromosome
complement on formation and severity of AngII-induced AAAs, sham-operated and
OVX female Ldlr-/- mice were infused with AngII for 1 month. Body weights of
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AngII-infused OVX XY female mice were decreased significantly compared to
OVX XX females (Table 2.4). Plasma renin concentrations were not significantly
different between XX and XY AngII-infused females (Table 2.4). Serum
testosterone concentrations were modestly, but significantly increased in AngIIinfused sham-operated XY compared to XX females, and elevations of serum
testosterone concentrations in XY females were eliminated by OVX (Table 2.4).
While sex organ weights of XX and XY females were significantly decreased by
OVX in XX and XY females, there were no differences between genotypes (Table
2.4). At study endpoint, internal abdominal aortic lumen diameters of XY females
with an AAA (as defined by a 50% increase in lumen diameter) were elevated (by
66%) significantly compared to XX females (Figure 2.2A; OVX groups).
Moreover, external

AAA diameters were

increased significantly in XY

compared to XX females (Figure 2.2B; OVX groups). AAA incidence (including
aneurysm ruptures) increased (by 31%) in XY females (Figure 2.2C) to levels
observed previously in XY male mice (Henriques, Huang et al. 2004, Henriques,
Zhang et al. 2008). In XX females (sham or OVX), there were no aneurysm
ruptures (Figure 2.2D). In contrast, 35% of XY sham-operated females infused
with AngII exhibited aneurysm ruptures, with high rupture rates also observed
in OVX XY females (29%). Aortas from XY females demonstrated severe
aneurysm pathology that frequently extended the entire length of the aorta and
was associated with aneurysm rupture (Figure 2.2E; Figure 2.9). As these
effects were observed in OVX XY females (Figure 2.2A-E), results suggest that
an XY sex chromosome complement augments AAA formation and severity
independent of female sex hormones.
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To define characteristics of AAAs from XY females, we performed ex vivo
3-D ultrasound on AAAs from each genotype (Figure 2.10). Results
demonstrate increased aneurysm wall volume in AAAs from XY compared to
XX females, and 3-D remodeling from a representative AAA from each
genotype illustrates lumen dilation with marked vascular wall remodeling. There
were no overt differences in aortic wall morphology of abdominal aortic tissue
sections from non-infused XX versus XY female mice (Figure 2.11). However,
AAA tissue sections from AngII-infused XY females exhibited CD68
macrophage immunostaining in areas exhibiting breaks in medial elastin (Figure
2.12). An XY sex chromosome complement also increased significantly systolic
blood pressure responses of female mice infused with AngII (both sham and
OVX; Table 2.4). As infusion of AngII augments atherosclerosis in Ldlr-/- female
mice (Daugherty, Manning et al. 2000), we quantified the percent of the intimal
aortic surface within the aortic arch and thoracic aorta covered by atherosclerotic
lesions. There was not a significant effect of genotype on AngII-induced
atherosclerosis in thoracic aortas (Figure 2.13) or aortic arches (data not
shown). Moreover, there were no significant differences in serum cholesterol
concentrations between genotypes (Table 2.4).
2.3.3 Aortas from XY females exhibit augmented inflammatory gene expression,
matrix metalloproteinase (MMP) activity, and oxidative stress.
Gene arrays on abdominal aortas from non-infused XY females
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demonstrated increased expression of genes within inflammatory pathways
(Table 2.1), and AAA tissue sections of XY females exhibited positive CD68
immunostaining in areas exhibiting breaks in medial elastin (Figure 2.12). We
confirmed by RT-PCR increased mRNA abundance of IL1-β, a component of the
inflammasome linked to AAA formation, in abdominal aortas from XY Ldlr-/females (Figure 2.3A). Moreover, mRNA abundance of Tlr8 was increased
significantly in abdominal aortas of XY compared to XX females (OVX groups:
XX, 1.1 ± 0.2; XY, 2.4 ± 0.4 ∆∆Ct; p=0.017). Since immune cell gene pathways
were altered in abdominal aortas from XY females, we harvested bone marrow
cells from XX and XY Ldlr-/- females and differentiated them to macrophages.
Similar to findings from abdominal aortas, Tlr8 mRNA abundance was increased
significantly in bone marrow macrophages (BMM) from XY compared to XX
females (XX, 1.1 ± 0.2; XY, 2.3 ± 0.2 ∆∆Ct; p=0.0001). Moreover, IL1β protein
concentrations were increased significantly in media from incubated BMM of
Ldlr-/- XY compared to XX females (Figure 2.3B). Finally, plasma concentrations
of IL1β were increased significantly in AngII-infused XY compared to XX Ldlr-/females (Figure 2.3C). As inflammatory genes with increased expression in
abdominal aortas from XY females have been linked to activation of MMPs and
oxidative stress, two mechanisms implicated in AAA formation and severity
(Kadoglou and Liapis 2004, Keeling, Armstrong et al. 2005, Emeto, Moxon et al.
2016), we quantified MMP activity in aortas of female XX and XY mice infused
for 1 day with AngII. Aortas from XY females infused with AngII exhibited
significant increases in MMP2 activity compared to XX females (Figure 2.4A,
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B). Moreover, when aortas were incubated in vitro with AngII and testosterone
to simulate conditions where AAA incidence and severity are augmented,
DHE fluorescence was pronounced in aortas from XY compared to XX
females (Figure 2.4C, D).
2.3.4 Testosterone exposure (as neonates or adults) results in a striking level of
aneurysm rupture in XY females.
Castration of male mice has been demonstrated to reduce the incidence of
AngII- induced AAAs (Henriques, Huang et al. 2004), while administration of DHT
augments AAA formation in adult female hypercholesterolemic mice (Henriques,
Zhang et al. 2008). To determine if testosterone exerted similar effects to promote
AAAs in females with an XX versus an XY sex chromosome complement, we
used two different paradigms to androgenize females of each genotype by
administering an equivalent dose of androgen. We administered the nonaromatizable ligand of the androgen receptor, DHT, to adult female Ldlr-/- XX and
XY mice prior to and throughout AngII infusions. There were no significant
differences in body weight (XX, 28 ± 1; XY, 27 ± 1g; P=0.45), sex organ weights
(XX, 0.09 ± 0.01; XY, 0.07 ± 0.02 g; P=0.46) and systolic blood pressures (XX,
129 ± 4; XY, 128 ± 7 mmHg; p=0.90) between AngII-infused XX and XY females.
Plasma IL1β concentrations were increased significantly in XY compared to XX
AngII-infused females (XX, 1.8 ± 0.9; XY, 15.5 ± 4.8; P<0.05). Both genotypes
AAA incidences when exposed to DHT (XX, 94%; XY, 100%), and abdominal
aortic lumen diameters were similar (Figure 2.14A). However, while 44% of XX
females administered DHT died of aneurysm rupture, 73% of XY females
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succumbed to rupture (Figure 2.5A; Figure 2.14B). External AAA diameters of
the few surviving XY females administered DHT were increased significantly
compared to XX females (Figure 2.5B). Due to the extreme incidence of
aneurysm rupture and extensive pathology of aortas from XY female mice
administered DHT, atherosclerosis could not be quantified. Recent studies
demonstrated that transient neonatal exposure of female hypercholesterolemic
mice to testosterone resulted in increased adult susceptibility to AngII-induced
AAAs (Zhang, Thatcher et al. 2012). Therefore, we administered testosterone to
1 day old XX and XY female Ldlr-/- mice and examined effects of AngII infusions
on AAA formation and severity in adult OVX females. There were no significant
differences in body weight, serum cholesterol concentrations and systolic blood
pressures between AngII-infused XX and XY females (data not shown). As
reported previously, transient neonatal exposure to testosterone promoted a high
incidence of AngII-induced AAAs in adult XX (50%) and XY (58%) females.
However, aneurysm ruptures increased significantly in XY (58%) compared to XX
(0%) females administered testosterone as neonates (Figure 2.6)
2.4 Discussion
The field of sexual dimorphism in normal vascular physiology and disease
is in its infancy as relates to the influence of sex chromosomes. However, the sex
chromosomes are one of the most unusual chromosomal differences in mammals,
with approximately 1,098 genes (Ross, Grafham et al. 2005) and more than 300
diseases alone mapped to the X chromosome. While there are fewer proteincoding genes on the Y chromosome, genes within the MSY have been linked to

51

different forms of cardiovascular diseases (Bloomer, Nelson et al. 2013). As an
example of sex chromosome influences on the vasculature, females with
monosomy X exhibit a 100-fold increased risk of aortic dissection (Wong, Burgess
et al. 2014), but mechanisms for these effects are unknown. Our results
demonstrate that an XY sex chromosome complement results in increased
expression of inflammatory gene pathways in abdominal aortas of female mice.
Further, the incidence and severity of AngII-induced AAAs, a vascular disease
associated with pronounced inflammation, was increased profoundly in XY
females. We demonstrate that elevated expression of inflammatory genes is linked
to increased MMP activity and oxidative stress in aortas of XY females, effects
known to promote AAA formation and severity. Finally, exposure of XY females
to testosterone to mimic the male sex hormone milieu resulted in a striking level
of aneurysm rupture. These results advance knowledge by demonstrating a
profound effect of sex chromosome complement on aortic biology and vascular
disease development. Moreover, results indicate a complex interplay between
sex hormones (e.g., testosterone) and sex chromosomes to regulate aortic biology
and vascular diseases, which may have cardiovascular implications for chronic sex
hormone therapy in the aging and/or trans- gender population. A positive family
history of AAA in a first degree relative has been suggested to increase the risk of
aortic aneurysm by up to 10-fold (Johansen and Koepsell 1986), indicating genetic
contribution to AAA pathogenesis. However, despite the strong predisposition for
AAA formation in males, the contribution of sex chromosome effects to AAA
inheritance and sexual dimorphism of this vascular disease has not been
investigated extensively. Clifton et al, originally described a family of three affected
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brothers diagnosed with an AAA (Clifton 1977). Follow-up studies demonstrated
that 77% of affected individuals in a cohort of 233 families were male and 79% of
disease transmissions were between father and son (Kuivaniemi, Shibamura et
al. 2003), suggesting male-lineage transmission of risk. It is unclear from the
present study whether increased AAA incidence and severity of XY females
resulted from the absence of a second X chromosome, or from presence of genes
on the Y chromosome. However, as XY females exhibiting high AAA incidence
and severity inherited the Y-chromosome from male fathers, these results suggest
that male-lineage may contribute to increased inherited risk of AAAs through
influences of the Y chromosome. These results are the first to demonstrate that
sex chromosome complement influences expression levels of 88 genes in
abdominal aortas of phenotypically normal females. Of note, the high
preponderance of changes in expression levels of inflammatory genes indicates
potential predisposition to effects of an inflammatory aneurysm stimulus such as
AngII. Recent studies identified sex differences in immune cells as contributors
to sexual dimorphism of blood pressure responses to AngII (Ji, Zheng et al.
2010; Pollow, Uhrlaub et al. 2014). Our results demonstrate increased mRNA
abundance of two inflammatory pathways typically associated with immune
cells, namely IL- 1β and Tlr8, in abdominal aortas of XY compared to XX aortas,
and elevated plasma IL1β concentrations in XY compared to XX AngII-infused
females. As elevated Tlr8 expression was also detected in BMM from XY
females, these results suggest a contribution of immune cells to baseline
differences in abdominal aortic inflammatory gene expression profiles between
XX and XY females. Following infusion of AngII, AAAs in XY females had
pronounced macrophage composition, elevated MMp-2 activity and aortas from
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XY females responded to AngII and testosterone with increased oxidative stress,
suggesting a robust inflammatory immune cell response that contributed to
increased AAA severity. These results are in agreement with recent findings
demonstrating immune cells as mediators of sex differences in response to AngII
infusions (Ji, Zheng et al. 2010; Pollow, Uhrlaub et al. 2014), and suggest that
sex chromosomes may contribute to sexual dimorphism of this immune cell
response. Previous findings from our laboratory demonstrated a prominent role
for testosterone to promote AngII-induced AAAs (Henriques, Huang et al. 2004;
Henriques, Zhang et al. 2008). In this study, an XY sex chromosome
complement increased the severity of AngII- induced AAAs in female mice.
These results are the first to demonstrate a profound effect of sex chromosome
complement, independent of sex hormones, to regulate the severity of AngIIinduced AAAs. As testosterone is also a powerful positive regulator of AAA
susceptibility in this experimental model, we used two different paradigms of
testosterone exposure to examine interactions between sex hormones (e.g.,
testosterone) and sex chromosomes. Moreover, as serum testosterone
concentrations were modestly different between XX and XY females,
administration of DHT to adult females to normalize androgen concentrations
between genotypes minimized the possibility that modest differences in serum
testosterone are a primary mechanism for augmented formation and severity of
AngII-induced AAAs in XY females. Results demonstrate a striking level of
aneurysm rupture (up to 73%) when XY females were exposed to testosterone
as neonates (Zhang, Thatcher et al. 2012) or adults (Henriques, Zhang et al.
2008). The magnitude of the effect of testosterone to promote the aneurysm
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rupture, larger than exhibited previously by XY males infused with AngII
(Daugherty, Manning et al. 2000; Henriques, Huang et al. 2004; Henriques, Zhang
et al. 2008), may have resulted from the dose of androgen. In addition, while
females are typically resistant to AAA development (both humans and AngIIinduced mice), AAAs in females grow at more rapid rates and rupture at smaller
sizes (Grootenboer, Bosch et al. 2009; Sweeting, Thompson et al. 2012;
Thompson, Brown et al. 2013; Skibba, Evans et al. 2015). Differences in the
physical size, compliance or stiffness of female abdominal aortas (Ninomiya,
Tavares Monteiro et al. 2015) may have contributed to more severe effects of
androgen to promote aneurysmal rupture of XY female mice. An interesting finding
from this study was increased blood pressure responses, as well as modest
elevations in thoracic aorta atherosclerotic lesion surface area in AngII- infused
XY compared to XX female mice. These results suggest that an XY sex
chromosome complement influences distinct cardiovascular responses (AAA,
hypertension, atherosclerosis) to AngII. In contrast to these findings, recent studies
demonstrated that an XX sex chromosome complement in gonadectomized MF1
mice contributed to a greater blood pressure response to AngII (Ji, Zheng et al.
2010). Differences in genetic background (MF1 versus Ldlr-/-) or diet (standard
murine diet versus Western diet) may have contributed to diverging influences of
sex chromosome complement on AngII-induced hypertension between studies.
Regardless, it is unlikely that the augmented hypertensive responsiveness to AngII
of XY females contributed to the robust severity of AAAs, as previous studies
suggested that blood pressure was not a major contributor to AngII-induced AAAs
(Cassis, Gupte et al. 2009). Future studies will address whether similar or distinct
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mechanisms contribute to augmentation of three different cardiovascular effects
of AngII in mice with an XY sex chromosome complement. However, as results
from DNA arrays do not indicate differences in expression levels of angiotensin
receptors in abdominal aortas of XX versus XY females, and plasma renin
concentrations were not significantly different between AngII-infused XX and XY
females, these results do not support generalized enhanced responsiveness of XY
females to AngII. Using computer program scanned electronic medical records,
prevalence of confirmed transgender individuals was 4.4 (per 100,000) in 2006,
and 38.7 in 2014 (Roblin, Barzilay et al. 2016). Despite the growing prevalence of
the transgender population, literature on specific health outcomes for transgender
individuals consists of modest cross-sectional studies, some large retrospective
studies, small series and case reports. Of these, recent data suggest increased
risk of cardiovascular morbidity/mortality in transgender women (Elamin, Garcia et
al. 2010). However, the influence of chronic sex hormone therapy on
cardiovascular health in transgender women or men has not been examined
extensively. In addition to the transgender population, the use of sex hormone
therapy, specifically testosterone to improve sexual function in aging males and
females, has also increased. Our results suggest that sex chromosome
complement influences aortic biology and the development of AAAs, with an XY
sex chromosome complement having a profound effect to promote AAA severity.
As these effects were augmented in XY females administered testosterone, these
results suggest interactions between sex hormones and genes affected by sex
chromosomes. These results may have implications related to chronic sex
hormone therapy and the cardiovascular system in aging males or females, or in
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the growing transgender population.
In summary, we demonstrate that an XY sex chromosome complement
promotes expression of inflammatory genes in abdominal aortas of female mice
and predisposes to markedly severe AngII-induced AAAs. As 73% of XY female
mice exposed to testosterone (to mimic the male sex hormone milieu) exhibited
aneurysm rupture, these results demonstrate interactions between sex hormones
and genes influenced by sex chromosomes on aortic biology, vascular disease
development and severity. Future studies will use this information to develop AAA
therapies that have sex-specific efficacy.
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Table 2.1. Biological pathway analysis (DAVID) for genes overexpressed in XY
females. Gene Ontology categories, the number of significant genes (n) and
the probability that a greater or equal number would be found by chance (P
Value ≤ 0.01) are listed.
Upregulated in XY in Comparison
With XX

n

P Value

Immune response

40

8.10E-21

Chemotaxis

17

3.06E-13

Leukocyte activation

21

2.84E-11

Cell surface

23

3.82E-10

18

5.09E-09

Response to bacterium

13

3.73E-07

Carbohydrate binding

17

2.80E-06

Regulation of cytokine production

12

5.30E-06

8

1.07E-05

14

3.61E-05

6

6.28E-05

7

7.86E-05

Positive regulation of cytokine biosynthetic
process

6

3.83E-04

Phagocytosis

6

4.32E-04

Antigen processing and presentation of
peptide antigen

5

5.43E-04

20

5.89E-04

9

0.002015298

Regulation of inflammatory response

5

0.006337282

Lytic vacuole

9

0.006726649

11

0.006752388

Chemokine activity

4

0.009335703

Positive regulation of cell activation

6

0.009424794

Positive regulation of response to stimulus

Immune response–regulating signal
transduction
Hemopoiesis
Regulation of interferon-γ
production
Positive regulation of defense response

Positive regulation of macromolecule
metabolic process
Positive regulation of signal transduction

Regulation of phosphorylation
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Table 2.2. Primer sequences.
Genes screened Primers
Forward: 5’XX
CAAATGTTGCTTGTCTCGGTG-3’
female
Reverse: 5’- GTCAGTCGAGTGCACAGTTTgenotype
3’

XY
female
genotype

Forward: 5’- CTGGAGCTCTACAGTGATGA3’
Reverse: 5’CAGTTACCAATCAACACATCAC-3’

IL1ß

Forward: 5’-TGC CAC CTT TTG ACA
GTG ATG-3’
Reverse: 5’-ATG TGC TGC TGC GAG
ATT TG-3’

Tlr8

Forward: 5’-TGG TTT TCA GTG GAA
ATC GT-3’
Reverse: 5’-CTC TGA GGC AAA TTG
AGG AA-3’

Beta actin

Forward: 5’-GCT CTG GCT CCT AGC
ACC AT-3’
Reverse: 5’-GCC ACC GAT CCA CAC
AGA GT-3’

GAPDH

Forward: 5’- GCCAAAAGGGTCATCATCTC3’
Reverse: 5’GGCCATCCACAGTCTTCT-3’

Kdm5d

Purchased from QIAGEN catalog #QT00155106

Uty

Purchased from QIAGEN catalog #QT00108157

Eif2s3y

Purchased from QIAGEN catalog #QT00149436

Xist

Purchased from QIAGEN catalog #330001 PRM68756B
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Table 2.3. Complete list of DNA array results.
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Probe Set ID
TC0500002508.mm.1
TC0600003071.mm.1
TC0X00001700.mm.1
TC0600003079.mm.1
TC0100003146.mm.1
TC1100003401.mm.1
TC0800001624.mm.1
TC1100004059.mm.1
TC0500000468.mm.1
TC1100003055.mm.1
TC0600001532.mm.1
TC0600001397.mm.1
TC0600001398.mm.1
TC1500000641.mm.1
TC0300000903.mm.1
TC0X00001829.mm.1
TC0X00000166.mm.1
TC0Y00000235.mm.1
TC0Y00000006.mm.1
TC1500001300.mm.1
TC1400001439.mm.1
TC0100003533.mm.1
TC0100001574.mm.1
TC0300000695.mm.1
TC0500000361.mm.1
TC0400001599.mm.1
TC1300002654.mm.1
TC1000003213.mm.1
TC1700002343.mm.1
TC1100000475.mm.1
TC0X00003376.mm.1
TC0200002308.mm.1
TC0600002404.mm.1
TC0700004207.mm.1
TC0900002197.mm.1
TC0200004602.mm.1
TC0700001877.mm.1
TC0700001876.mm.1
TC0300000767.mm.1
TC0X00001541.mm.1
TC0Y00000005.mm.1
TC0X00000190.mm.1
TC0500000710.mm.1
TC0700000773.mm.1
TC0700002143.mm.1
TC1400001054.mm.1

Gene
Apbb2
Apobec1
Arhgap6
C3ar1
Camsap2
Ccl3
Cd209b
Cd300e
Cd38
Cd68
Clec12a
Clec4a1
Clec4a3
Csf2rb
Ctss
Cybb
Ddx3x
Ddx3y
Eif2s3y
Fam105a
Fam107a
Fcer1g
Fcgr4
Fcrl5
Fgfr3
Fgr
Gapt
Gp49a
Gtf2f1
Havcr2
Hccs
Hck
Hpgds
Igsf6
Il10ra
Il1b
Itgad
Itgax
Kcnn3
Kdm5c
Kdm5d
Kdm6a
Kit
Klk10
Lair1
Lcp1

Location
Description
amyloid beta (A4) precursor protein-binding, family B, membchr5
apolipoprotein B mRNA editing enzyme, catalytic polypeptid chr6
Rho GTPase activating protein 6
chrX
complement component 3a receptor 1
chr6
calmodulin regulated spectrin-associated protein family, me chr1
chemokine (C-C motif) ligand 3
chr11
CD209b antigen
chr8
CD300e antigen
chr11
CD38 antigen
chr5
CD68 antigen
chr11
C-type lectin domain family 12, member a
chr6
C-type lectin domain family 4, member a1
chr6
C-type lectin domain family 4, member a3
chr6
colony stimulating factor 2 receptor, beta, low-affinity (gran chr15
cathepsin S
chr3
cytochrome b-245, beta polypeptide
chrX
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked chrX
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked
chrY
eukaryotic translation initiation factor 2, subunit 3, structurachrY
family with sequence similarity 105, member A
chr15
family with sequence similarity 107, member A
chr14
Fc receptor, IgE, high affinity I, gamma polypeptide
chr1
Fc receptor, IgG, low affinity IV
chr1
Fc receptor-like 5
chr3
fibroblast growth factor receptor 3
chr5
Gardner-Rasheed feline sarcoma viral (Fgr) oncogene homol chr4
Grb2-binding adaptor, transmembrane
chr13
glycoprotein 49 A
chr10
general transcription factor IIF, polypeptide 1
chr17
hepatitis A virus cellular receptor 2
chr11
holocytochrome c synthetase
chrX
hemopoietic cell kinase
chr2
hematopoietic prostaglandin D synthase
chr6
immunoglobulin superfamily, member 6
chr7
interleukin 10 receptor, alpha
chr9
interleukin 1 beta
chr2
integrin, alpha D
chr7
integrin alpha X
chr7
potassium intermediate/small conductance calcium-activate chr3
lysine (K)-specific demethylase 5C
chrX
lysine (K)-specific demethylase 5D
chrY
lysine (K)-specific demethylase 6A
chrX
kit oncogene
chr5
kallikrein related-peptidase 10
chr7
leukocyte-associated Ig-like receptor 1
chr7
lymphocyte cytosolic protein 1
chr14

Summary Statistics
XX OVX
XX sh
XY OVX
XY sh
9.53 ± 0.02 9.46 ± 0.06 9.28 ± 0.06 9.22 ± 0.06
8.81 ± 0.09 8.78 ± 0.05
9.3 ± 0.14 9.51 ± 0.18
7.3 ± 0.12
6.14 ± 0.13 6.29 ± 0.14 7.35 ± 0.09
6.98 ± 0.16 6.98 ± 0.11 7.45 ± 0.15 7.75 ± 0.14
11.43 ± 0.06 11.33 ± 0.02 11.29 ± 0.03 11.13 ± 0.04
4.7 ± 0.03 4.82 ± 0.06 5.24 ± 0.09 5.12 ± 0.07
6.78 ± 0.18 7.04 ± 0.08 6.22 ± 0.12 6.29 ± 0.21
5 ± 0.16 4.91 ± 0.07 6.36 ± 0.22 6.54 ± 0.38
8.54 ± 0.1 8.28 ± 0.12 9.03 ± 0.09
8.85 ± 0.1
8.81 ± 0.13 8.93 ± 0.17 9.93 ± 0.26 9.99 ± 0.28
6.83 ± 0.12 6.68 ± 0.05 7.33 ± 0.17 7.42 ± 0.19
7.49 ± 0.18 7.36 ± 0.11 8.24 ± 0.17 8.51 ± 0.27
7.58 ± 0.22 7.59 ± 0.15 8.48 ± 0.24 8.66 ± 0.22
6.55 ± 0.15 6.53 ± 0.08 7.16 ± 0.12 7.06 ± 0.18
10.86 ± 0.19 10.53 ± 0.26 11.76 ± 0.25 11.63 ± 0.23
9.67 ± 0.08 9.59 ± 0.17 10.43 ± 0.18 10.48 ± 0.18
15.98 ± 0.09 15.84 ± 0.05 15.29 ± 0.05 15.22 ± 0.05
5.4 ± 0.43 4.95 ± 0.09 11.59 ± 0.05 11.63 ± 0.04
5.34 ± 0.24 5.13 ± 0.06
9.3 ± 0.09 9.27 ± 0.14
6.61 ± 0.05 6.62 ± 0.05 6.92 ± 0.07 6.93 ± 0.11
7.87 ± 0.21 7.78 ± 0.15 6.71 ± 0.17 6.75 ± 0.17
7.96 ± 0.15 8.04 ± 0.15 8.68 ± 0.14
8.8 ± 0.28
4.23 ± 0.1 4.24 ± 0.11 6.03 ± 0.27 6.49 ± 0.63
5.4 ± 0.25
4.53 ± 0.08 4.44 ± 0.08 5.09 ± 0.19
5.93 ± 0.06 5.96 ± 0.03 5.68 ± 0.05 5.69 ± 0.06
4.94 ± 0.04 4.95 ± 0.05 5.37 ± 0.09 5.43 ± 0.09
5.05 ± 0.05
4.9 ± 0.09
4.56 ± 0.1 4.68 ± 0.06
6.02 ± 0.14 6.02 ± 0.12 6.82 ± 0.18 6.93 ± 0.19
9.85 ± 0.03 9.74 ± 0.03 9.63 ± 0.02 9.63 ± 0.03
5.05 ± 0.07 4.81 ± 0.09 5.48 ± 0.12
5.3 ± 0.12
7.09 ± 0.13 7.05 ± 0.05 7.92 ± 0.12 7.87 ± 0.09
6.04 ± 0.04 5.98 ± 0.09
6.5 ± 0.15 6.71 ± 0.12
6.68 ± 0.07
6.7 ± 0.06 7.07 ± 0.09 7.09 ± 0.09
8.25 ± 0.13 8.17 ± 0.07 8.67 ± 0.11 8.86 ± 0.09
6.39 ± 0.03 6.07 ± 0.13
6.7 ± 0.09 6.82 ± 0.19
4.79 ± 0.12 4.79 ± 0.11
5.4 ± 0.14 5.33 ± 0.11
4.31 ± 0.02 4.24 ± 0.03 4.44 ± 0.03 4.46 ± 0.08
5.4 ± 0.03 5.26 ± 0.07 6.21 ± 0.15
5.87 ± 0.1
7.21 ± 0.14 7.13 ± 0.13 6.57 ± 0.13 6.62 ± 0.14
9.81 ± 0.03 9.97 ± 0.05 8.96 ± 0.04 8.99 ± 0.01
4.55 ± 0.07 4.59 ± 0.04 7.51 ± 0.06 7.52 ± 0.05
10.45 ± 0.1 10.44 ± 0.08 9.44 ± 0.04 9.38 ± 0.06
8.24 ± 0.12
7.98 ± 0.1
9.13 ± 0.2 8.75 ± 0.22
8.15 ± 0.33
8.3 ± 0.25 6.86 ± 0.19 6.87 ± 0.21
5.67 ± 0.03 5.64 ± 0.08 6.06 ± 0.09 6.24 ± 0.16
9.19 ± 0.12 8.93 ± 0.16 9.72 ± 0.15 9.8 ± 0.22

two way ANOVA p-values
Chromo
0.000345
0.000137
1.26E-07
0.000648
0.000735
3.15E-05
0.000433
4.28E-06
0.000108
0.000155
0.000699
9.26E-05
0.000335
0.000504
0.000744
9.71E-05
2.23E-08
3.66E-15
6.66E-15
0.00053
1.73E-05
0.000723
7.03E-06
0.000286
0.000112
1.4E-05
0.000569
8.14E-05
3.7E-05
0.000468
1.12E-06
8.52E-05
0.000175
8.64E-05
0.000331
0.000368
0.000313
6.08E-06
0.000569
3.26E-14
1E-15
2.1E-10
0.000169
6.56E-05
5.96E-05
0.000539

Ovari
0.257841
0.487314
0.695655
0.32801
0.005569
0.980155
0.27764
0.830034
0.058844
0.683757
0.83046
0.710377
0.664626
0.651629
0.356963
0.925871
0.139071
0.375221
0.421577
0.894979
0.868094
0.586716
0.459132
0.541518
0.725643
0.616178
0.848676
0.725819
0.082951
0.059858
0.683081
0.530356
0.78459
0.626271
0.408151
0.786215
0.611081
0.038162
0.933502
0.016949
0.634494
0.644227
0.075816
0.766636
0.423855
0.605799

Intrxn
0.889473
0.326819
0.413062
0.318426
0.470016
0.120149
0.54
0.553348
0.714304
0.900525
0.41952
0.288328
0.728257
0.774829
0.69331
0.701381
0.645657
0.298022
0.553468
0.984008
0.712431
0.918285
0.483174
0.242513
0.848324
0.697492
0.112749
0.730542
0.048839
0.788712
0.957103
0.272399
0.975462
0.216542
0.072737
0.781576
0.249165
0.378912
0.610502
0.115453
0.793738
0.736706
0.74018
0.788322
0.275352
0.311689

two way ANOVA q-values
Chromo
0.037033
0.004874
3.22E-07
0.046839
0.048576
0.000106
0.038526
1.6E-06
0.004664
0.010205
0.047298
0.003467
0.037015
0.039305
0.049345
0.004066
1.31E-07
1.03E-11
1.33E-11
0.041936
5.36E-05
0.047971
1.16E-05
0.026099
0.004825
1.93E-05
0.042833
0.002533
0.000131
0.038915
3.82E-07
0.002954
0.01048
0.003211
0.030845
0.03733
0.027611
2.76E-06
0.043013
1.4E-11
1.46E-11
1.7E-11
0.01044
0.002111
0.001598
0.042227

Ovari
1.164919
1.06745
1.016022
1.119491
1.163697
1.001036
1.149303
1.007484
1.421551
1.019112
1.007475
1.014658
1.023691
1.026858
1.112081
1.002422
1.33292
1.104861
1.083873
1.003472
1.006558
1.036311
1.076754
1.045654
1.013585
1.032865
1.007232
1.013582
1.411203
1.422871
1.019503
1.051434
1.008278
1.031983
1.086046
1.008255
1.033999
1.399297
1.002113
1.300452
1.031604
1.030776
1.41461
1.00968
1.083382
1.034705

Intrxn
1.111467
1.613141
1.443566
1.628218
1.358128
2.40378
1.283321
1.268139
1.169321
1.108882
1.435849
1.73007
1.164646
1.149171
1.178238
1.173661
1.202931
1.695561
1.267791
1.087295
1.170395
1.105141
1.344875
1.850602
1.124339
1.176624
2.423412
1.163499
3.121616
1.141877
1.094368
1.790958
1.088956
1.934873
2.814019
1.146221
1.828807
1.499077
1.232068
2.411896
1.140753
1.160713
1.158979
1.141941
1.778139
1.646642

Chromo
Fold
Change
1.19
-1.50
-2.16
-1.50
1.11
-1.35
1.58
-2.78
-1.46
-2.12
-1.52
-1.89
-1.96
-1.50
-2.02
-1.77
1.57
-86.63
-16.67
-1.24
2.14
-1.66
-3.94
-1.66
1.19
-1.36
1.28
-1.80
1.12
-1.39
-1.78
-1.49
-1.31
-1.45
-1.43
-1.49
-1.13
-1.68
1.50
1.89
-7.68
2.04
-1.83
2.56
-1.39
-1.61

Table 2.3. Continued.
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TC1900000221.mm.1
TC1900001131.mm.1

Ms4a6c
Ms4a7

membrane-spanning 4-domains, subfamily A, member 6C
membrane-spanning 4-domains, subfamily A, member 7

chr19
chr19

TC0X00003371.mm.1
TC1700000585.mm.1
TC1900001156.mm.1
TC0X00001054.mm.1
TC1900001506.mm.1
TC0500003463.mm.1
TC0500003464.mm.1
TC0500003465.mm.1
TC1200001272.mm.1
TC1200001972.mm.1
TC0X00003361.mm.1
TC1000001688.mm.1
TC0800000368.mm.1
TC1500001520.mm.1
TC1400000325.mm.1
TC1900001390.mm.1
TC0100001568.mm.1
TC0100003550.mm.1
TC0100001615.mm.1
TC0100000632.mm.1
TC1700001634.mm.1
TC0100001932.mm.1
TC0X00000979.mm.1
TC0500002480.mm.1
TC0X00001069.mm.1
TC0X00003360.mm.1
TC0X00003359.mm.1
TC0X00003159.mm.1
TC0X00003358.mm.1
TC0400003957.mm.1
TC1700000934.mm.1
TC0Y00000233.mm.1
TC1000001490.mm.1
TC0X00002775.mm.1
TC1200002082.mm.1
TC0400001607.mm.1
TC0Y00000224.mm.1
TC1900000246.mm.1

Msl3
Myo1f
Olfr76
Pbdc1
Pik3ap1
Pilra
Pilrb1
Pilrb2
Pld4
Plek2
Prps2
Rgs17
Rnf122
Samd12
Sema3g
Sgms1
Sh2d1b1
Slamf7
Slamf9
Slc11a1
Slc9a3r2
Sntg1
Taf1
Tlr1
Tlr13
Tlr7
Tlr8
Tmem29
Tmsb4x
Tnfrsf1b
Treml4
Uty
Wif1
Xist
Ltbp2
Map3k6
Mid1
Mpeg1

male-specific lethal 3 homolog (Drosophila)
chrX
myosin IF
chr17
olfactory receptor 76
chr19
polysaccharide biosynthesis domain containing 1
chrX
phosphoinositide-3-kinase adaptor protein 1
chr19
paired immunoglobin-like type 2 receptor alpha
chr5
paired immunoglobin-like type 2 receptor beta 1
chr5
paired immunoglobin-like type 2 receptor beta 2
chr5
phospholipase D family, member 4
chr12
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chr12
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chrX
regulator of G-protein signaling 17
chr10
ring finger protein 122
chr8
sterile alpha motif domain containing 12
chr15
sema domain, immunoglobulin domain (Ig), short basic dom chr14
sphingomyelin synthase 1
chr19
SH2 domain protein 1B1
chr1
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chr1
SLAM family member 9
chr1
solute carrier family 11 (proton-coupled divalent metal ion t chr1
solute carrier family 9 (sodium/hydrogen exchanger), memb chr17
syntrophin, gamma 1
chr1
TAF1 RNA polymerase II, TATA box binding protein (TBP)-ass chrX
toll-like receptor 1
chr5
toll-like receptor 13
chrX
toll-like receptor 7
chrX
toll-like receptor 8
chrX
transmembrane protein 29
chrX
thymosin, beta 4, X chromosome
chrX
tumor necrosis factor receptor superfamily, member 1b
chr4
triggering receptor expressed on myeloid cells-like 4
chr17
ubiquitously transcribed tetratricopeptide repeat gene, Y ch chrY
Wnt inhibitory factor 1
chr10
inactive X specific transcripts
chrX
latent transforming growth factor beta binding protein 2
chr12
mitogen-activated protein kinase kinase kinase 6
chr4
clone MEX2A-1 Mid1 mRNA, partial sequence.
chrY
macrophage expressed gene 1
chr19
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Lilrb3
Lilrb4

leukocyte immunoglobulin-like receptor, subfamily B (with T chr7
leukocyte immunoglobulin-like receptor, subfamily B, memb chr10

8.07 ± 0.12 7.97 ± 0.13 8.63 ± 0.16 8.78 ± 0.22
5.65 ± 0.07 5.66 ± 0.09 6.13 ± 0.15 6.44 ± 0.17
9.27 ± 0.16 9.21 ± 0.05 10.63 ± 0.04 10.51 ± 0.06
6.23 ± 0.07 6.27 ± 0.07 6.66 ± 0.11 6.75 ± 0.11
4.61 ± 0.06 4.56 ± 0.08 4.22 ± 0.06 4.29 ± 0.09
6.58 ± 0.03
6.5 ± 0.04 5.99 ± 0.04
6.1 ± 0.06
7.18 ± 0.11 7.06 ± 0.14 7.65 ± 0.13
7.8 ± 0.2
5.52 ± 0.08 5.45 ± 0.04
6.04 ± 0.1 6.18 ± 0.11
5.35 ± 0.11 5.48 ± 0.06
5.7 ± 0.08
5.9 ± 0.1
4.73 ± 0.05 4.73 ± 0.07 5.09 ± 0.13 5.32 ± 0.11
9.14 ± 0.13 9.02 ± 0.08 9.77 ± 0.22 9.99 ± 0.28
7.51 ± 0.19 7.81 ± 0.11
6.9 ± 0.13
6.98 ± 0.2
10.34 ± 0.07
10 ± 0.11 11.21 ± 0.1 11.21 ± 0.17
6.92 ± 0.08
6.58 ± 0.1 6.07 ± 0.12 6.04 ± 0.21
5.5 ± 0.04 5.45 ± 0.05 5.78 ± 0.07 5.78 ± 0.08
8.29 ± 0.15 8.16 ± 0.13 7.67 ± 0.13
7.6 ± 0.13
6.96 ± 0.12 7.29 ± 0.13 6.65 ± 0.13 6.46 ± 0.09
7.25 ± 0.04 7.27 ± 0.05 7.05 ± 0.03 7.08 ± 0.02
4.75 ± 0.07 4.86 ± 0.03 5.22 ± 0.08 5.36 ± 0.16
6.27 ± 0.13
5.78 ± 0.2 6.86 ± 0.18 6.89 ± 0.23
6.69 ± 0.22 6.67 ± 0.13 7.28 ± 0.13 7.43 ± 0.09
7.15 ± 0.11 7.22 ± 0.06 7.57 ± 0.09 7.76 ± 0.15
9.79 ± 0.08 9.77 ± 0.04 9.29 ± 0.11 9.13 ± 0.05
4.56 ± 0.05
4.6 ± 0.02 4.39 ± 0.02 4.42 ± 0.01
9.65 ± 0.04 9.58 ± 0.02 9.47 ± 0.02
9.5 ± 0.03
4.73 ± 0.09
4.5 ± 0.15
5.17 ± 0.1 5.24 ± 0.16
5.51 ± 0.1 5.15 ± 0.11 5.82 ± 0.08 5.82 ± 0.12
7.45 ± 0.07
7.32 ± 0.1 8.88 ± 0.09 8.83 ± 0.17
6.85 ± 0.19 6.82 ± 0.09 8.46 ± 0.12 8.64 ± 0.23
5.38 ± 0.03 5.38 ± 0.03 5.17 ± 0.02 5.18 ± 0.04
11.14 ± 0.08 11.12 ± 0.07 11.44 ± 0.06 11.42 ± 0.02
7.85 ± 0.05 7.78 ± 0.07 8.18 ± 0.07 8.12 ± 0.07
4.4 ± 0.09 4.31 ± 0.12 4.87 ± 0.11 4.92 ± 0.09
8.7 ± 0.14
4.94 ± 0.13 4.86 ± 0.04 8.76 ± 0.05
5.18 ± 0.1 4.88 ± 0.04 5.57 ± 0.09 5.34 ± 0.12
13.54 ± 0.12 13.72 ± 0.12
4.8 ± 0.07 4.86 ± 0.09
6.5 ± 0.13 6.41 ± 0.04 6.94 ± 0.08 6.74 ± 0.09
7.14 ± 0.16 7.15 ± 0.08 6.72 ± 0.07 6.7 ± 0.04
9.1 ± 0.14 8.91 ± 0.18 9.78 ± 0.11 9.92 ± 0.09
9.14 ± 0.18 8.74 ± 0.22 10.05 ± 0.21 10.01 ± 0.35
6.52 ± 0.1 6.51 ± 0.11 6.96 ± 0.11 7.21 ± 0.21
7.81 ± 0.16 7.74 ± 0.19 8.65 ± 0.2 8.77 ± 0.15
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1.001983
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-1.52
-2.53
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Table 2.4. Characteristics of female XX and XY mice infused with AngII.
Parameter

XX

Sham
Ovx
Body weight (g)
25.6 ± 0.7
27.5 ± 0.6
123 ± 4
123 ± 3
Systolic Blood
Pressure mmHg
0.11 ± 0.03
0.15 ± 0.03
Serum
Testosterone ng/ml
1964 ± 335
1934 ± 144
Serum
Cholesterol mg/dl
0.21 ± 0.11
0.26 ± 0.08
Plasma Renin
Concentration ng/ml
Sex Organ Weights (g) 0.13 ± 0.02
0.04 ± 0.01*
Data are mean ± SEM from n=10-17/group.
*, P<0.05 compared to Sham within genotype.
**, P<0.05 compared to XX within surgical group.
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XY
Sham
25.1 ± 0.7
131 ± 4**

Ovx
23.9 ± 0.7**
129 ± 4**

0.36 ± 0.12** 0.11 ± 0.05*
1405 ± 107

1721 ± 246

0.13 ± 0.06

0.25 ± 0.09

0.11 ± 0.02 0.04 ± 0.01*

Figure 2.1 Sex chromosome complement influences abdominal aortic gene expression
patterns. (A) Left, total number of probe sets on arrays filtered to retain transcripts with
reliable signal intensity (FDR; False Discovery Rate). Right, number of genes whose
expression level was significantly altered by main effect of genotype (XX, XY), surgery
(ovariectomy, OVX, sham surgery) and interaction between genotype and surgery. (B),
Volcano plot illustrating fold change in gene expression (x-axis) and statistical
significance (y-axis). Genes labelled in blue exhibited significant increase in XY
compared to XX abdominal aortas; genes labelled in red exhibited significant increase
in XX aortas. (C), RT-PCR of selected abdominal aortic genes illustrated in (B). A,B:
Filtered array data analyzed by 2-way ANOVA. C, 2-way ANOVA; data are mean ±
SEM from n = 5 mice/surgery group/genotype. *, P<0.05 compared to XX within
surgical group. **, P<0.05 compared to sham within genotype.
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Figure 2.2. An XY sex chromosome complement markedly promotes formation and
severity of AngII- induced AAAs in female mice. (A), Internal abdominal aortic lumen
diameters over time of AngII infusions from mice of each genotype (OVX groups; n =
10-17 mice/genotype at study onset) that exhibited a 50% increase in lumen diameter
over baseline, and that survived the 28 day infusion protocol. (B), Maximal external AAA
diameters after 28 days of AngII infusion mice with an AAA (from A). Symbols represent
individual mice with mean ± SEM as horizontal lines. (C), AAA incidence (which
includes aneurysm rupture). The number of mice with an AAA/total number of mice in
each group is illustrated above each bar of the histogram. (D), % ruptured AAAs. (E)
Aortas from mice of each genotype. Data were analyzed by (A) two way repeated
measures ANOVA, (B) unpaired t-test (C) and (D) Fisher's exact test. *, P<0.05
compared to XX within surgical group.
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Figure 2.3. IL1β expression in abdominal aortas (A), bone marrow-derived
macrophages (BMM, B) and plasma (C) of XX and XY Ldlr-/- females. For A, IL1β

mRNA abundance was quantified by RT-PCR in abdominal aortas from XX and XY
Ldlr-/- ovariectomized females. For B, cells were harvested from bone marrow of
XX and XY Ldlr-/- females and differentiated in vitro to macrophages. IL1β
concentrations were quantified in media of BMM cells of each genotype incubated
with LPS. For C, plasma IL1β concentrations were quantified from XX and XY Ldlr/- females infused with AngII for 28 days. Data were analyzed by Mann-Whitney
test. Circles represent data from individual mice while mean ± SEM are illustrated
by horizontal lines. *, P<0.05 compared to XX.
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Figure 2.4. Aortas from XY females exhibited augmented MMP2 activity (A, B) and
dihydroethidium (DHE) fluorescence (C,D). A, Zymograms of aortic extracts from
XX and XY Ldlr-/- females infused with AngII for 1 day. B, MMP2 (64 kDa) activity
quantified by densitometric scans of

zymograms (n

= 4/genotype). C,

Representative images of DHE stained aortic explants from XX and XY Ldlr-/females incubated with vehicle (V) or AngII+testosterone (10 μM and 10 nM,
respectively; T=testosterone). D, Quantification of DHE staining in aortic explant
sections from XX and XY females. *, P<0.05 compared to XX (B, or within treatment
group in D). **, P<0.05 compared to vehicle.
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Figure 2.5. Severe AAA rupture in XY females administered dihydrotestosterone
(DHT). Adult female XX (n=18) and XY mice (n=11) were administered DHT (0.16
mg/d) for 2 weeks prior to and throughout AngII infusions. (A) % AAA rupture in
XX and XY females. (B) Maximal AAA diameters at study endpoint. Symbols
represent individual mice with horizontal lines representing mean ± SEM. Data
analyzed by (A) Fisher’s exact test (B) Unpaired t-test. *, P<0.05 compared to
XX+DHT.
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Figure 2.6. Administration of testosterone (400 μg) to 1 day old neonatal female XY
mice results in severe AAA rupture when adult XY females are infused with AngII.
Females (n=6 XX, n=12 XY) were administered a single dose of testosterone within
24 hours of birth, and then infused with AngII at 2 months of age. Top, % AAA
rupture. Bottom, representative aortas from mice of each group. Data were
analyzed using Fisher’s exact test. *, P<0.05 compared to XX.
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Figure 2.7. mRNA abundance of GAPDH in abdominal aortas from XX and XY Ldlr-/females. Data were analyzed by 2-way ANOVA. Symbols represent individual mice,
while horizontal lines represent mean ± SEM.
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Figure 2.8. Immune/ inflammatory signaling is upregulated in the aortas of females
with an XY chromosomal complement. The standardized gene expression values for
each subject in each treatment group are heatmapped (scale bar: -2 to +2 standard
deviations) for the top 50 most significant genes by the main effect of chromosome
(two-way ANOVA, p ≤ 0.0005). 37/50 genes (left) are expressed more strongly in XY
subjects. 86% of these (bolded symbols) have known roles in immune/ inflammatory
processes (Gene Ontology annotation search; orange- promote signaling; blue- inhibit
signaling).
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Figure 2.9. Aneurysm type as an index of severity of AAAs (top) and Kaplan Meier
Survival Curve (bottom, OVX groups) from XX and XY Ldlr-/- females infused with
AngII. Type 1, dilated lumen in the supra-renal region of the aorta with no thrombus;
Type II, remodeled tissue in the supra-renal region that frequently contains thrombus;
Type III, a pronounced bulbous form of type II that contains thrombus; Type IV, a form
in which there are multiple aneurysms containing thrombus, some overlapping, in the
suprarenal area of the aorta; Rupture, aneurysms from mice that died of verified
rupture. Data are illustrated as percent of total mice within each group.
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Figure 2.10. Abdominal aortas from XY females infused with AngII exhibit
increased wall volume (top). Bottom, representative 3-D reconstruction from
ex vivo ultrasound analysis of one AAA/genotype. Data were analyzed by
unpaired t-test; data are mean ± SEM.
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Figure 2.11. Morphology of abdominal aorta from XX versus XY females prior
to AngII infusions. Representative abdominal aorta tissue sections from noninfused XX and XY females stained with hematoxylin and eosin. Scale bar
represents 100 µm.
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Figure 2.12. Representative AAA tissue sections from XY females infused
with AngII exhibit pronounced CD68 immunostaining in areas exhibiting
breaks in medial elastin. Scale bar represents 200 µm.
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Figure 2.13. Sex chromosome complement has no significant effect on AngIIinduced atherosclerosis in thoracic aortas. Data were analyzed by weighted
two- way ANOVA. Symbols represent individual mice with mean ± SEM
represented by horizontal lines.
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Figure 2.14. Abdominal aortic lumen diameters (A) and survival plots (B) over
days of AngII infusions of XX and XY Ldlr-/- females administered DHT. A, Data
were analyzed by 2-way ANOVA with repeated measures on time. B, Kaplan
Meier curve for survival of mice in each treatment group. Data are mean ±
SEM from n=11-18 mice/genotype.
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CHAPTER III. SPECIFIC AIM 2
Sex chromosome complement defines diffuse versus focal angiotensin IIinduced aortic pathology (Published in ATVB)
Authors: Yasir Alsiraj, Sean E. Thatcher, Eric Blalock, Bradley Fleenor, Alan
Daugherty, and Lisa A. Cassis.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2018;38:143-153
URL: http://atvb.ahajournals.org.ezproxy.uky.edu/content/38/1/143.long
Summary
Objective-Aortic pathologies exhibit sexual dimorphism, with aneurysms in both
the thoracic and abdominal aorta (AAA) exhibiting higher male prevalence.
Women have lower prevalence of aneurysms, but when they occur, aneurysms
progress rapidly. To define mechanisms for these sex differences, we determined
the role of sex chromosome complement and testosterone on the location and
progression of angiotensin II (AngII)-induced aortic pathologies.
Approach and Results-We used transgenic male mice expressing Sry on an
autosome to create low density lipoprotein receptor (Ldlr) deficient male mice with
an XY or XX sex chromosome complement.

Transcriptional profiling was

performed on abdominal aortas from XY or XX males, demonstrating 1746 genes
influenced by sex chromosomes or sex hormones. Males (XY or XX) were either
sham-operated or orchiectomized prior to AngII infusions. Diffuse aortic aneurysm
pathology developed in XY AngII-infused males, while XX males developed focal
AAAs. Castration reduced all AngII-induced aortic pathologies in XY and XX
males.

Thoracic aortas from AngII-infused XY males exhibited adventitial

thickening that was not present in XX males. We infused male XY and XX mice
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with either saline or AngII and quantified mRNA abundance of key genes in both
thoracic and abdominal aortas. Regional differences in mRNA abundance existed
before AngII infusions, which were differentially influenced by AngII between
genotypes. Prolonged AngII infusions resulted in aortic wall thickening of AAAs
from XY males, while XX males had dilated focal AAAs.
Conclusions-An XY sex chromosome complement mediates diffuse aortic
pathology, while an XX sex chromosome complement contributes to focal AngIIinduced AAAs.
3.1 Introduction
Aortic vascular diseases are life-threatening conditions that are not typically
symptomatic, which is of concern since ruptures result in high morbidity and
mortality. Amongst the various risk factors that have been identified for aortic
vascular diseases, male sex has emerged as a positive risk factor for aneurysmal
disease in the ascending aorta (AA) (Roman et al. 2017), distal thoracic aorta
(TAA) (Cheung et al. 2017), and for abdominal aortic aneurysms (AAAs)
(Pleumeekers et al. 1995; Zarrouk et al. 2013; Svensjo et al. 2013; Weiss et al.
2014; Vardulaki et al. 1998; Pleumeekers et al. 1994). Recent studies analyzing
patients within the Genetically Triggered Thoracic Aortic Aneurysms and
Cardiovascular Conditions (GenTAC) registry demonstrated that adult males with
Marfan syndrome were more likely than females to have aortic root dilatation (by
8%), aortic regurgitation (by 19%) and the prevalence of previous aortic dissection
tended to be higher in males (by 7%) (Singh et al. 2017). Similarly, TAAs are also
more prevalent in men (Olsson et al. 2006). Male sex is considered one of the
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largest non-modifiable risk factors for AAAs, with estimates ranging from a 2-10
fold greater prevalence in men compared to women (Weiss et al. 2014; Wilmink et
al. 1998; Pleumeekers et al. 1994; Morris et al. 1994).

A higher prevalence of

aortic vascular diseases in men is not restricted to aneurysms, as the incidence of
acute aortic dissection is also higher in men than women (Clouse et al. 2004;
Wenger et al. 1993; Maitusong et al. 2016). Despite a uniformly lower incidence
of various forms of aortic vascular diseases in women compared to men,
paradoxically, women exhibit more rapid growth rates of both TAAs and AAAs
than men, and aneurysms rupture at smaller sizes (Juvonen et al. 1997; Davies et
al. 2002; Nienaber et al. 2004; Cheung et al. 2017; Grootenboer et al. 2009;
Skibba, 2015; Sweeting et al. 2012; Thompson et al. 2013).

Mechanisms for

these sex differences in aortic vascular disease development versus progressive
growth have not been defined. Similar to humans, studies from our laboratory
demonstrated that AAAs induced by infusion of angiotensin II (AngII) to
hypercholesterolemic mice exhibit a high level of sexual dimorphism, with a 4-fold
higher AAA prevalence in male compared to female mice (Henriques et al, 2004).
Testosterone was identified as a primary contributor to higher AAA prevalence in
AngII-infused male mice (Henriques et al. 2004; Henriques et al. 2008; Thatcher
et al. 2014; Thatcher et al. 2015).

Moreover, administration of testosterone to

neonatal female low density lipoprotein receptor (Ldlr) deficient mice infused with
AngII augmented development of aneurysms in the ascending and abdominal
aorta (Zhang et al. 2012). Adult female mice exposed to testosterone as neonates
maintained a high susceptibility to AngII-induced aortic vascular diseases (Zhang
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et al. 2012). In contrast, AAA incidence was markedly reduced when adult male
mice were castrated (Henriques et al. 2004). These results suggest that while
testosterone is a primary mediator of sexual dimorphism of experimental aortic
vascular diseases, other differences between males and females may contribute
to sexual dimorphism of vascular disease development and severity. In addition to
sex hormones, recent studies demonstrated that an XY sex chromosome
complement was sufficient to promote a high level of AAA susceptibility in female
Ldlr-/- mice infused with AngII (Alsiraj et al. 2017).

Moreover, XY females

exhibited increased aneurysm rupture, which rose to 73% when females were
exposed to dihydrotestosterone to mimic an adult male milieu. These results
suggest that sex chromosome complement also has profound effects on the
vasculature, which is of interest as women with Turner’s Syndrome (monosomy
X) exhibit a 100-fold increased risk of aortic dissection (Wong et al. 2014). The
purpose of this study was to define the relative role of sex hormones versus sex
chromosome complement on the location and characteristics of aortic vascular
diseases following AngII infusions. The four core genotype murine (FCG) model
was utilized to assess the relative role of sex hormones versus sex chromosome
complement on the formation and progression of AngII-induced AAAs.

This

model produces mice in which the sex chromosome complement (XX versus XY)
is varied independently of gonadal sex (testes versus ovaries). The FCG model
was created from a natural mutation of the Sry gene (testis determining gene) on
the Y chromosome of mice (XY-), where an Sry transgene was inserted onto an
autosome for testes formation and fertility (XY-Sry) (Itoh et al, 2015). Breeding of
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XY-Sry male mice to XX females produces FCG: XX and XY males, XX and XY
females. Since testosterone promotes AngII-induced AAs and AAAs in male mice
(Henriques et al. 2004; Henriques et al. 2008), we performed studies on male
Ldlr- /- mice with an XY and an XX sex chromosome complement in the presence
or absence of male sex hormones. Since men experience a higher prevalence of
AAs, TAAs, and AAAs than women, we hypothesize that testosterone and an XY
sex chromosome complement promote vascular disease along the length of the
aorta in male mice infused with AngII.
3.2 Methods
3.2.1 Mice.
All studies using mice were approved by the institutional Animal Care and
Use Committee at the University of Kentucky and conformed to the Guide for the
Care and Use of Laboratory Animals published by the NIH. Male transgenic mice
with deletion of Sry from the Y-chromosome expressing Sry on an autosome (812 weeks of age) were backcrossed 10 times on a C57BL/6J background
(Stock#010905, The Jackson Laboratories, Bar Harbor MA) and bred to low
density liproprotein receptor deficient (Ldlr-/-) females (Stock# 002207, The
Jackson Laboratories, Bar Harbor MA) to generate Ldlr-/- male mice with an XY or
an XX sex chromosome complement. DNA was extracted from ear or tail clips and
subjected to PCR using a commercial PCR mix (Promega 2X Master Mix,
cat#m7123, Fitchburg WI) and specific primers. For transcriptome analysis, male
XY and XX Ldlr-/- mice (n = 4-5/group/genotype) were randomly assigned to sham
and orchiectomized (ORC) groups. Following surgery, mice were fed a Western
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diet (TD88137, Harlan Teklad, Indianapolis, IN) for 2 weeks prior to euthanasia
and tissue harvest. For assessment of aortic vascular pathologies (Figure 1A),
male XY and XX mice (n = 19-21/group/genotype) bred from transgenic male Sry
mice were randomly assigned to sham and ORC groups. In addition, we included
XY male Ldlr-/- mice (n = 10) purchased from The Jackson Laboratories (Stock#
002207, Bar Harbor MA) to compare to XY males generated from our transgenic
Sry Ldlr-/- colony. As there were no observed differences in data quantified from
Ldlr-/- XY males (Sry-bred or from The Jackson Laboratory), data from XY males
were pooled between strain sources. Two weeks after surgery, mice were fed the
Western diet for 1 week prior to implantation of osmotic minipumps and then
through study endpoint. Anesthetized mice were implanted subcutaneously with
osmotic minipumps (Alzet model 1004, Durect Co., Cupertino, CA) for infusion of
AngII for 28 days (1,000 ng/kg/min, Bachem, Torrance, CA). Ultrasound was
performed on anesthetized mice on day 0, 7, 14 and 27 of AngII infusions. In this
study, n = 6 sham-operated male XX mice, n = 2 ORC male XX mice, n = 2 shamoperated male XY mice and n = 2 ORC male XY mice died from aneurysm rupture,
and thus were not included in some AAA quantification measurements (internal
aortic diameters, external AAA diameter). For aortic regional mRNA abundance,
male XY and XX Ldlr-/- mice (n = 6-8 mice/sex) were infused with saline or AngII
(1,000 ng/kg/min) for 1 day prior to euthanasia and tissue harvest. For prolonged
infusion of AngII (Figure 1B), male XY and XX Ldlr-/- mice (n = 19 XY, n = 8 XX)
were fed the Western diet for one week prior to implantation of osmotic minipumps
containing AngII (1,000ng/kg/min) and the diet continued through study endpoint.
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Ultrasound was used on day 27 of AngII infusions to define mice with an AAA
(abdominal aortic lumen diameter > 50% increase compared to day 0 of infusions).
For each genotype, all mice infused with AngII qualified with an AAA and thus
continued in the study. Osmotic minipumps were replaced with fresh AngII solution
every 28 days in anesthetized mice. Ultrasound was performed on anesthetized
mice on day 0, 14, 27, 42, 56 and 70 of prolonged AngII infusions. In this study, n
= 9 male XY mice and n = 3 male XX mice died from AAA rupture and thus were
not included in some measures of AAA quantification (e.g., ultrasound or maximal
AAA diameters). Thus, illustrated data for these measurements represent mice
that survived the 70 days of AngII infusions. At the end of each experiment, mice
were euthanatized under anesthesia (ketamine/xylazine, 100:10 mg/kg, i.p.) and
blood was collected via cardiac puncture.
3.2.2 Orchiectomy.
Male (8-12 weeks of age) XX and XY Ldlr-/- mice were orchiectomized
under isoflurane anesthesia (2-3%) and given pre and post-operative analgesic
(24 hr after surgery; flunixin; 2.5 mg/kg). Mice were shaved in the scrotum region
and a depilatory cream (Nair, Inc.) applied to the area to remove hair, followed by
sterilizing with povidone-iodine/ethanol (three times). A small incision was made in
this region. Vas deferens were collapsed using a hemostat and the testes were
removed. The vascular supply was ligated by cauterization using a hightemperature fine-tip loop cauterizer and the hemostat was released. The wound
site was monitored for bleeding, and the skin was closed by wound clips (Autoclip
stapler). The site was then treated with povidone-iodine, and mice were allowed to
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recover. The testes were manipulated but left intact in anesthetized sham-operated
mice. All mice were allowed to recover from surgery and to clear their endogenous
testicular hormones for two weeks before the onset of AngII infusions.
3.2.3 Measurement of plasma and serum components.
Total serum cholesterol and testosterone concentrations were determined
using enzymatic assay kits (Wako Pure Chemical, Richmond, VA, cat#439-17501;
Alpco, Salem, NH, cat#55-TESMS-E01; respectively). The renin concentration in
plasma was measured by quantifying angiotensin I generated in the absence or
presence of an excess of exogenous rat angiotensinogen (purified from
nephrectomized rat plasma). Plasma was harvested from mice in ice-cold EDTA
(0.2 M). Mouse plasma (8 μl) was incubated in buffer (Na2HPO4, 0.1M; EDTA,
0.02 M; maleate buffer, pH 6.5; total volume of 250 μl) containing
phenylmethylsulfonyl fluoride (2 μl/250μl reaction volume) for 30 minutes at 37°C
in a shaking water bath. The reaction was terminated by placing samples at 100°C
for 5 min. Angiotensin I was quantified by radioimmunoassay using a commercial
kit (DiaSorin, CA-1553, Stillwater, MN). Plasma renin concentration (ng/ml) is
represented as the difference in angiotensin I levels in the absence versus the
presence of exogenous angiotensinogen.
3.2.4 Blood pressure measurements.
Blood pressure was quantified using a non-invasive computerized tail-cuff
method (BP-2000; Visitech Systems, Apex, NC) at baseline (prior to pump
implantation) and during week 3 of AngII infusion. Measurements were recorded
at the same time of the day for 5 days (2 days acclimation, 3 days of recording).
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3.2.5 Quantification of AAAs.
The abdominal aortic internal lumen diameters were quantified on day 0, 7,
14, and 28 of AngII infusions using a Vevo 2100 high-resolution imaging system
(VisualSonics, Inc.). AAA incidence was quantified from the abdominal aortic
internal lumen diameter, and defined as a 50% increase in lumen diameter on day
28 of AngII infusions (compared to day 0). AAA incidence included mice that died
from aneurysm rupture, which was visually confirmed post-mortem. Other
measurements (ultrasound, maximal AAA diameters) included mice that survived
the complete study protocol. External abdominal aortic diameters were quantified
on excised, cleaned tissue mounted on a black wax background. A Nikon SMZ800
dissecting microscope was used to obtain aorta images and the maximal external
diameter of the abdominal aorta was quantified. Using the Vevo 2100 system with
a 55-MHz probe, the three-dimensional volume analysis was performed on
abdominal aortas of XX and XY males (n = 5 mice/genotype) that were infused
with AngII for 3 months. Aortas were scanned at the abdominal region (diaphragm
to the ileac bifurcation) using the ultrasound ex vivo at 0.051 mm intervals with an
imaging length of 14.986 mm, and a total of 295 images were collected. Each
image was analyzed for wall and lumen volume, and images were combined to
obtain the total volume of abdominal aortas.
3.2.6 Quantification of AAs and TAAs.
Arch areas were defined by drawing a 3-mm line from the left subclavian
artery. Thoracic areas were defined by drawing a 9mm line from the end of the
arch area to the diaphragm muscle. Arch and thoracic combined areas were
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quantified by drawing a line around the borders and summing the total area of
each. Measurements were performed using Nikon Elements Version 3.2.
3.2.7 Quantification of atherosclerosis.
Atherosclerosis was quantified en face in the aortic arch (Daugherty et al.
2000). Lesions were summed and divided by the total arch area to calculate the
percent lesion area. Cleaned aortas were cut open longitudinally and mounted on
a black wax background using insect pins (Fine Science Tools, cat# 26002-20) to
quantify atherosclerosis in the aortic arch and the thoracic aorta.
3.2.8 Quantification of aortic stiffness (pulse wave velocity, PWV).
Aortic stiffness was assessed on anesthetized (2% isoflurane) male XY and
XX mice (8 months of age, non-infused, n = 6 mice/genotype) that were placed
supine on a heating board with legs secured to ECG electrodes (Du et al. 2015).
Doppler probes (Indus Instruments, Webster, TX) were used to noninvasively
quantify aortic velocities at the aortic arch and abdominal aorta.

PWV was

calculated as the distance between the aortic arch and abdominal probes divided
by the difference in thoracic and abdominal aortic pre-ejection times. Data are
presented as centimeters/second.
3.2.9 Quantification of adventitial and medial diameter in thoracic aorta tissue
sections.
Thoracic aortic segments from XY and XX male mice (n = 3 mice/ group)
infused with AngII for 28 days were formalin fixed, processed through a series of
ethanol and xylene baths and embedded in paraffin. Sets of serial 5 micron cross
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sections were collected at intervals along each segment and stained with
hematoxylin and eosin. Six tissue sections from each mouse were imaged using a
Nikon Eclipse 80i microscope. The adventitial layer was defined by encircling a
line around the borders of the outer layer of the aortic section. The medial layer
was defined by encircling a line around the borders of the middle layer of the aortic
section. Analysis was performed using Nikon Elements Version 3.2.
3.2.10 RNA extraction and DNA microarrays.
XY and XX male mice (8 weeks of age; n = 4-5 mice/ genotype) underwent
sham surgery or ORC, and after two weeks, mice were placed on Western diet
(TD88137, Harlan Teklad, Indianapolis, IN) for one week. RNA from abdominal
aortas was extracted using the RNeasy fibrous tissue mini kit (Qiagen, cat #
74704). Harvested abdominal aortic RNA quality and quantity were measured by
Agilent 2100 Bioanalyzer using RNA 6000 Nano Labchip kits (Agilent
Technologies, Cat # 5067-151). One RNA sample (subject #9) was excluded due
to poor quality. The remaining 17 samples had excellent quality and did not differ
significantly by treatment group (RNA Integrity Number [RIN]: 9.64 ± 0.03; RNA
concentration (ng/ul): 55.7 ± 7.4; 28s:18s ratio: 3.00 ± 0.07; all p-values for main
effects of gene and surgery, as well as of interaction terms were n.s. [p > 0.1]).
Extracted RNA was labeled and hybridized to Affymetrix Mouse Transcriptome
Assay 1.0 arrays (one array per subject; n = 17). Signal intensities were calculated
using the RMA algorithm (Bolstad et al, 2003) at the transcript level using
Genomics Suite software (Partek, St Louis). Data were transferred to flat files in
Excel and associated with vendor-provided annotation data. Pre-statistical filtering
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retained unique, annotated probe sets with adequate signal intensity (signal
intensity ≥ 4.2 on at least 3 arrays in the study). Filtered signal intensities were
analyzed by two-way ANOVA to identify significant main effects of genotype (XY
versus XX), surgery (Sham vs ORC), as well as interaction. The False Discovery
Rate (FDR) procedure (Hochberg et al. 1990) was used to estimate the error of
multiple testing. Functional categorization for each expression pattern was
determined with the prestatistically filtered gene list as a background using
DAVID bioinformatic tools (Huang da et al. 2009). Currently, DAVID does not
support Affymetrix MTA 1.0 IDs, and therefore best match IDs from Affymetrix
Mouse 1.0 Exon arrays were used, covering more than 90% of the filtered MTA
data set. Raw data are available through the Gene Expression Omnibus (GSE
#:81580 www.ncbi.nlm.nih.gov/geo/).
3.2.11 Real Time RT-PCR.
After 1-day of saline or AngII infusion to XY and XX male Ldlr-/- mice (n =
4-6 mice/ genotype/ treatment) RNA was extracted from abdominal and thoracic
regions of the aorta using the RNeasy fibrous tissue mini kit (Qiagen, cat # 74704).
cDNA was then synthesized using the qScript cDNA Supermix (Quanta
Biosciences, cat# 95048-500). Real-time PCR was processed using the SYBER
Green FastMix (Quanta Biosciences, cat# 95071-012) on a BioRad quantitative
real-time PCR. mRNA abundance was determined using the ∆∆Ct method. Gene
expression was normalized to the housekeeping gene, beta-2-microglobulin.
Primers sequences for the probed genes are listed in Table 1.
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3.2.12 Statistical Analyses.
Data are illustrated as mean ± SEM. Data were analyzed using unpaired
Student t-tests for two groups, by two-way repeated measures ANOVA on time for
longitudinal data with between group factors of surgery or genotype, or by two or
three-way ANOVA with between group factors of surgery, region, treatment or
genotype. If differences existed between groups, a Holm-Sidak post hoc analysis
was performed. Incidence of AAAs and TAAs were analyzed by Fisher’s exact
test when two groups were examined. Statistical analysis was performed using
SigmaPlot software (Version 12.3) or GraphPad Prism 5. P≤ 0.05 was considered
significant.
3.3 Results
3.3.1 Testosterone and/or Sex Chromosome Complement Influenced Abdominal
Aortic Gene Expression Patterns and Aortic Stiffness.
We demonstrated recently that an XY sex chromosome complement promoted
expression of inflammatory gene pathways in abdominal aortas from female Ldlr/- mice (Alsiraj et al, 2017). Since previous studies focused on abdominal aortas
of XX and XY females, in this study we used RNA extracted from abdominal aortas
of XY and XX male mice (non-infused) that were gonadally intact (sham-operated)
or orchiectomized (ORC) for Affymetrix Mouse Transcriptome Assay 1.0 analysis.
A total of 1,746 genes exhibited highly significant differences (two-way ANOVA,
P<0.01, Figure 2A). There was a significant main effect of sex chromosome (450
genes, FDR = 0.32), castration (799 genes, ORC vs Sh, FDR = 0.14) and an
interaction between sex chromosome and castration (708 genes, FDR = 0.24;
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Figure 2). A frequency histogram of the number of genes (y-axis) found at different
p-value cut-offs (x-axis), with chance depicted by the dashed line, illustrates the
number of genes influenced by sex chromosome complement, castration, or by an
interaction between sex chromosomes and sex hormones at different p-values
(Figure 2). Volcano plots of the chromosome effect with highly stringent cutoffs (>
2-fold change, p < 0.01) demonstrated that, as expected, the expression of genes
on sex-chromosomes was influenced strongly (Figure 2).

Using this level of

stringency, five genes (Xist, Arntl, Npas2, Arhgap20, Ighv14-1) were increased
significantly in abdominal aortas of sham-operated XX compared to XY males
(Figure 2, Table 2). In contrast, 51 genes were increased significantly in abdominal
aortas of sham-operated XY compared to XX males (Table 2). RT-PCR on mRNA
extracted from abdominal aortas from mice of each genotype and surgical group
confirmed microarray results for selected genes enriched in XX (Xist, Npas2, Arntl,
Figure 3) or XY aortas (Cyp2e1, Kap, Figure 3). Biological pathway analysis
revealed several expression patterns, potentially related to aortic vascular
diseases, that were increased in abdominal aortas of XY compared to XX males
(immune response, acute inflammatory response), while other pathways were
increased in abdominal aortas of XX compared to XY males (e.g., DNA binding,
regulation of cell proliferation) (Figure 2, Table 3). To determine if differences in
gene expression patterns (e.g., extracellular matrix, Figure 2) between aortas of
XY and XX males influenced aortic function, we quantified pulse wave velocity
(PWV) as an index of aortic stiffness in non-infused XY and XX Ldlr-/- males.
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Aortas from XY males exhibited significant increases in PWV compared to XX
males (Figure 4).
3.3.2 Aortic Aneurysmal Disease was Diffuse in XY Males and Localized in XX
Males.
At study endpoint, body weights of castrated (ORC) male mice infused with
AngII were decreased significantly compared to sham-operated controls,
regardless of genotype (Table 4; P<0.05). Serum testosterone concentrations
were similar in sham-operated XY and XX males infused with AngII (Table 4;
P>0.05).

Castration resulted in significant decreases in serum testosterone

concentrations of both genotypes, with no differences between genotypes (Table
4; P<0.05). Systolic blood pressures were not different between genotypes or
surgical groups at baseline (XY sham, 111 ± 4; XY ORC, 109 ± 5; XX sham, 110
± 3; XX ORC, 107 ± 2 mmHg), but increased significantly in AngII-infused XY
compared to XX sham-operated males (Table 4; P<0.05), and this difference was
eliminated by castration.

Plasma renin concentrations were not significantly

different between groups (Table 4; P>0.05). Atherosclerotic lesion surface area in
the aortic arch was not significantly altered by castration or by sex chromosome
complement in AngII-infused male mice (Table 4; P>0.05).
Aortas from XY sham-operated AngII-infused males exhibited diffuse disease that
typically extended from the aortic arch to the suprarenal aorta (Figure 5A, top left).
In contrast, aortas from XX AngII-infused males exhibited aortic pathology that was
generally restricted to the suprarenal portion of the abdominal aorta (Figure 5A,
top right). As an index of the extent of aortic pathology, aorta weights were
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increased significantly in XY compared to XX males, with aortic weights decreased
by castration in both genotypes (Figure 5B; P<0.05). The area of the aortic arch
was increased significantly in XY compared to XX AngII-infused sham-operated
males (Figure 5C; P<0.05), with reductions in arch areas following castration of XY
males. The incidence of aneurysms in the aortic arch or thoracic aorta (TAAs) was
markedly higher in XY (44%) compared to XX (8%) AngII-infused males (Figure
5D; P<0.05). This difference was abolished by castration, which resulted in almost
complete ablation of AngII-induced TAAs in both genotypes. In contrast to diffuse
aortic disease of XY males infused with AngII, XX males exhibited focal aortic
disease within the suprarenal portion of the abdominal aorta, with significant
increases in external AAA diameters that were abolished by castration (Figure 6A;
P<0.05). Similarly, abdominal aortic lumen diameters were increased significantly
in XX compared to XY sham-operated males infused with AngII (day 28, Figure
6B; P<0.05). The high incidence of AAAs was not significantly different between
XX and XY AngII-infused males (Figure 6C; P>0.05), and castration significantly
decreased AAA incidences of both genotypes (Figure 6C; P<0.05). Larger AAAs
of XX males were associated with slight, but insignificant increases in aneurysmal
rupture (Figure 6D; P>0.05), which were also reduced by castration of XX males.
Since XY, but not XX males exhibited considerable aortic pathology in the thoracic
aorta, we characterized morphology of tissue sections prepared from thoracic
aortas of XY and XX males infused with AngII. Thoracic aorta tissue sections from
XY AngII-infused males exhibited pronounced thickening of the adventitia, which
was not evident in thoracic aortas of XX males (Figure 7A, B). Adventitial
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thickening of thoracic aortas from XY males was abolished by castration (Figure
7A, B). In contrast, medial diameters were not significantly different between XY
and XX males, and were not influenced by castration (Figure 7A, C; P>0.05).
3.3.3 Aortic Genes Related to AAA Development Exhibited Region-specific and
AngII-induced Differences in Abundance.
Initial studies defined gene expression patterns in abdominal aortas from
non-infused male XY and XX mice (Figure 2). To determine if differences in aortic
disease development between XY and XX male mice are associated with regional
differences in aortic gene expression, and whether AngII regulates aortic genes in
a region-specific manner, we contrasted effects of short-term (1 day) infusions of
saline versus AngII on abundance of genes within the thoracic versus abdominal
aortas of male XY and XX Ldlr-/- mice. We chose short-term AngII infusions to limit
the extent of overt aneurysm pathology between genotypes. Abundance of
angiotensin converting enzyme (ACE), collagen 1a1, and thrombospondin (Thbs1)
mRNAs were increased significantly in abdominal compared to thoracic aortas of
XX, but not XY saline-infused male mice (Figure 8A-D; P<0.05). Moreover,
abdominal aortas of saline-infused XX males exhibited significantly increased
mRNA abundance of ACE, collagen 1a1, and Thbs1 compared to abdominal
aortas of saline-infused XY males (Figure 8A, C,D; P<0.05). Infusion of AngII
resulted in significant elevations in mRNA abundance of matrix metalloproteinase
2 (MMP2), collagen 1a1, and Thbs1 in thoracic, but not abdominal aortas of XY
male mice compared to XY saline-infused controls (Figure 8B-D; P<0.05). In
contrast, abdominal aortas of XX males did not respond to AngII with increased
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expression of MMP2 or Thbs1. However, mRNA abundance of collagen 1a1 was
decreased significantly by AngII in abdominal aortas of XX males. As a result,
following AngII infusions, marked regional differences in expression levels of
MMP2, collagen 1a1, and Thbs1 were evident, with increased expression levels in
thoracic compared to abdominal aortas of XY and XX male mice (Figure 8B-D;
P<0.05). The magnitude of AngII-induced changes in the regional expression
levels of these genes were more pronounced in XY than XX male mice.
3.3.4 Regional Differences in AngII-induced Aortic Vascular Diseases Between XY
and XX Males Persisted with Aneurysm Progression.
Despite a lower prevalence of TAA and AAA development in women
compared to men, previous studies demonstrated that aneurysm growth rates are
more aggressive in women, and aneurysms may rupture at smaller sizes
(Juvonen et a. 1997; Davies et al. 2002; Nienaber et al. 2004; Cheung et al.
2017; Grootenboer et al. 2009; Skibba, 2015; Sweeting et al. 2012; Thompson et
al. 2013). Therefore, we examined progression of aortic vascular diseases in
response to 3 months of prolonged AngII infusions in XY and XX males. Increased
abdominal aortic lumen diameters of XX males persisted with prolonged AngII
infusions (Figure 9A; P<0.05). Surprisingly, dilated abdominal aortas of XX males
were not associated with significantly larger AAA diameters at study endpoint
(Figure 9B; P>0.05). These results suggest divergent aneurysm remodeling
between genotypes. Similar to 28 day AngII infusions, XY males infused with AngII
for 3 months exhibited diffuse aortic disease (Figure 9C), resulting in significant
increases in aorta weight (Figure 9D; P<0.05) and incidence of TAAs compared to
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XX males (Figure 9E; P<0.05). Since maximal AAA diameters were not different
between XY and XX males, but aneurysms of XX males were more dilated, we
performed ex vivo ultrasound analysis of AAA 3-D structures following prolonged
AngII infusions (Figure 10, representative 3-D images of AAA from each group in
C). AAA wall volumes were increased in XY compared to XX males (Figure 10A),
while AAA lumen volumes were increased significantly in XX compared to XY
males (Figure 10B).
3.4 Discussion
The key novel findings of this study are: (1) Male sex hormones, coupled
with an XY sex chromosome complement result in development of diffuse aortic
disease associated with adventitial thickening in response to AngII infusions. (2)
In contrast, an XX sex chromosome complement in phenotypic male mice results
in focal aneurysmal disease within the suprarenal abdominal aorta. (3) These
regional differences in aortic vascular disease development are associated with
differences in abundance of genes implicated in aneurysmal disease between
thoracic versus abdominal aortas of XY and XX male mice. (4) Short-term infusion
of AngII superimposes pronounced regional differences in aortic gene expression
in both genotypes, with greater differences in XY males. (5) Focal suprarenal AAAs
of AngII-infused XX males progress to exhibit pronounced aortic lumen dilation,
while progressing AAAs of XY males infused chronically with AngII have thickened
vascular wall volumes and aortas exhibit diffuse disease. It is well established that
male sex is a significant non-modifiable risk factor for development of AAAs, with
men exhibiting a 2-10-fold higher prevalence than women (Weiss et al. 2014;
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Wilmink et al. 1998; Pleumeekers et al. 1994; Morris et al. 1994). Recent results,
performed on a large population of well-characterized patients with Marfan
syndrome, also exhibited a higher prevalence of aortic root dilatation and
regurgitation in men compared to women (Roman et al. 2017). Moreover, using
data from the Swedish national healthcare registers from 1987 to 2002, the
incidence of TAA was 52% in men compared to 28% in women (Olsson et al.
2006). Collectively, these studies indicate that men exhibit a higher prevalence of
vascular disease localized to different regions of the aorta compared to women.
A variety of mechanisms for these differences have been proposed, ranging from
influences of sex hormones and their receptors (Villard et al. 2017), differences in
aortic stiffness (Tong et al. 2013), hemodynamic influences, and basic differences
in aortic size between sexes (Lindquist et al. 2017; Lo et al. 2014; Sweet et al.
2011; Lederle et al. 1997). Of interest, sex chromosome abnormalities, such as
Turners syndrome (monosomy X), are associated with a higher risk of aortic
dissection (Wong et al. 2014), another aortic vascular disease that exhibits higher
prevalence in men than women (Meszaros et al. 2000). Recent studies from our
laboratory demonstrated that an XY sex chromosome complement, when inserted
in phenotypic females with low circulating testosterone, was sufficient to increase
the incidence and severity of AngII-induced AAAs (Alsiraj et al. 2017). We also
noted that exposure of XY females to dihydrotestosterone, to mimic a male-like
milieu, resulted in a striking level of aneurysm rupture (Alsiraj et al. 2017). In this
study, we used male mice with an XY or XX sex chromosome complement, as
males experience testosterone exposures throughout life and testosterone has
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been demonstrated to increase AngII-induced AAAs in male or female mice
(Henriques et al. 2004; Henriques et al. 2008; Zhange et al. 2012). Our results
demonstrate that testosterone, through a sex chromosome-dependent (XY)
mechanism, promotes the presence of diffuse aortic vascular disease in male mice
infused with AngII. In contrast, aortas from XX males exhibit focal aortic pathology
manifest within the suprarenal region of the abdominal aorta, as has been typically
described for AngII-induced AAAs that occur in females (Daugherty et al. 2000).
These striking differences in regional location of AngII-induced aortic pathology
were both sex chromosome and sex hormone-mediated.
Several potential mechanisms have been suggested to contribute to sex
differences in aortic vascular disease development (Makrygiannis et al. 2014). In
this study, gene expression analysis exhibited 1746 genes that were differentially
expressed in abdominal aortas of non-infused XY and XX males according to sex
hormone (e.g., influenced by castration), sex chromosome complement, or by an
interaction between these factors. Pathway analysis of gene array data identified
genes related to extracellular matrix, acute inflammatory response, regulation of
cell proliferation and the immune response may relate to differences in AAA
susceptibility between males and females. Of the aortic genes exhibiting
pronounced differences based on sex chromosome complement, Xist, the RNA
gene within the X chromosome that is the effector of the X-inactivation process,
confirms the validity of sex chromosome manipulation in XX males. Arntl (BMAL1)
and Npas2, genes enriched in aortas from XX compared to XY males, are genes
expressing proteins that are core components of the circadian clock apparatus. To
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our knowledge, there is minimal information related to influences of circadian
rhythm on AAA formation and/or rupture. Abdominal aortas from XY males had
higher mRNA abundance of Cyp2e1 (a member of the cytochrome p450 enzyme
family) and Kap (kidney androgen-regulated protein) compared to XX males. It is
unclear if these differences in abdominal aortic gene expression between XY and
XX males are related to aneurysm outcomes of the current study.An intriguing
difference between XY and XX males infused with AngII was the large adventitial
thickening that occurred in the thoracic aorta of XY, but not XX males. Increased
adventitial thickening in response to AngII infusions in thoracic aortas may have
contributed to the observed augmented aortic stiffening of XY males (Bersi et al.
2016). Since blood pressures were increased significantly in XY compared to XX
males infused with AngII, it is possible that hemodynamic differences contributed
to these divergent morphologic responses and susceptibility to AngII-induced
TAAs between genotypes. However, blood pressure was similar in AngII-infused
sham and castrated males, even though TAA incidence was markedly reduced by
castration. These results suggest that blood pressure may not be the primary
contributor to the development of diffuse aortic vascular pathologies of XY males.
Previous investigators demonstrated a large number of genes (1475) that are
differentially expressed in the ascending versus descending aortas of female mice
(Pfaltzgraff et al. 2014). These differences were ascribed to developmental origins
of cells within distinct regions of the aorta. Specifically, smooth muscle cells of the
ascending aorta develop from cardiac neural crest and second heart field (Sawada
et al. 2017), descending aorta cells develop from somites while those of the
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abdominal aorta are derived from mesodermal origin (Majesky et al. 2007). These
differences have been suggested to contribute to diverging physiologic and
pathophysiologic responses of the aorta, including regulation of the extracellular
matrix (Thieszen et al. 1996; Majesky et al. 2007; Thatcher et al. 2015). Notably,
previous studies indicate that cells of mesodermal origin that populate the
abdominal aorta express androgen receptors (Cunha et al. 1981), and recent
studies indicate increased expression of androgen receptors in abdominal aortas
of patients with an AAA compared to control aorta (Villard et al. 2017). In this
study, with the exception of collagen 1, XY and XX males exhibited the opposite
patterns of gene expression in abdominal versus thoracic aortas, with increased
thoracic gene expression in XY males, and increased abdominal gene expression
in XX males. Notably, infusion of AngII resulted in robust regional differences in
expression patterns of several genes with more robust regional differences (e.g.,
higher in thoracic than abdominal) in aortas from XY males exhibiting diffuse
disease in response to the peptide. It is unclear if embryonic origins of vascular
wall cells contribute to the observed regional differences in aortic gene expression
patterns or the regional responses to AngII. Despite a lower prevalence of aortic
vascular disease in women than men, women with AAAs or TAAs appear to exhibit
more progressive aneurysmal growth, with a propensity to rupture at smaller
aneurysm sizes (Cheung et al. 2017; Lo et al. 2014; Thompson et al. 2013;
Sweeting et al. 2012; Larsson, 2011; Mofidi et al. 2007; Solberg et al. 2005).
Previous results from our laboratory demonstrated that castration of male mice
with established AngII-induced AAAs resulted in aneurysm remodeling, with thin
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walled AAAs of castrated males compared to muscularized aneurysms of
intact males (Zhang et al. 2015). Results of the current study agree with
previous findings, in that AAAs of XY males had large wall volumes as they
continued to grow. In addition, the diffuse nature of aortic vascular pathology
of XY males persisted with prolonged AngII infusions. In contrast, XX males
exhibited dilated thin walled AAAs with prolonged AngII infusions,
suggesting an increased propensity of weakened aortas to rupture. These
results indicate that sex chromosome-mediated influences on aortic vascular
biology may contribute to differences in the progression of aortic vascular
disease between sexes. A limitation of the model used in these studies is that
it does not define whether the observed phenotype results from genes
residing on the Y or second X chromosome (that escape X-inactivation).
Moreover, XX males that are derived from this breeding strategy are infertile
and have small testes because they lack the Y chromosome genes that are
responsible for spermatogenesis. However, as XX mice have serum testosterone
concentrations that are not significantly different from male XY mice (Table 4),
it is unlikely that these differences influenced experimental findings.
In conclusion, this is the first demonstration that sex chromosome complement,
coupled with sex hormones (e.g., testosterone), modulate the region-specific
development of aortic pathology in response to AngII. An XY sex chromosome
complement in males resulted in diffuse aneurysmal disease along the aorta, while
a male XX sex chromosome complement mediated focal abdominal aortic
aneurysmal disease.

These regional differences in aortic vascular disease
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according to sex chromosome complement were dependent on the presence of
male sex hormones. Regional differences in expression levels of genes implicated
in aneurysm development between thoracic versus abdominal aortas from XY and
XX males may contribute to divergent aneurysm susceptibility and regional
location of aortic pathology between sexes in response to AngII. Finally, aneurysm
progression and remodeling were differentially regulated by sex chromosome
complement, with XX males exhibiting thin walled AAAs and XY males exhibiting
thickened AAAs and diffuse aortic disease from prolonged AngII infusions. These
studies suggest that sex differences between men and women in development and
progression of aortic vascular diseases may arise from the complex interplay
between sex hormones and sex chromosome complement in defining regional
aortic gene expression, diffuse versus focal aortic pathology, and differential
aneurysm remodeling of aortic vascular diseases.
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Table 3.1. Primer sequences for RT-PCR.
Gene

Primer sequence

ACE

Forward: 5’-AGGTTGGGCTACTCCAGGAC-3’
Reverse: 5’-GGTGAGTGTTGTCTGGCTTC-3’

MMP2

Forward: 5’-GGGGTCCATTTTCTTCTTCA-3’
Reverse: 5’-CCAGCAAGTAGATGCTGCCT-3’

Collagen1

Forward: 5’-GCTCCTCTTAGGGGCCACT-3’
Reverse: 5’-CCACGTCTCACCATTGGGG-3’

Thbs1

Forward: 5’-CAATTTTCAGGGGGGTGCTGC-3’
Reverse: 5’-CCGTTCACCACGTTGTTGTC-3’

Xist

Purchased from QIAGEN catalog#330001 PPM68756B

Kap

Purchased from QIAGEN catalog#QT00113484

Cyp2e1

Purchased from QIAGEN catalog#QT02280278

Arntl

Purchased from QIAGEN catalog#QT00101647

Npas2

Purchased from QIAGEN catalog#QT00108647
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Table 3.2. Upregulated genes in XY vs. XX males
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Table 3.3. Biological pathways upregulated in XY and XX males
Upregulated in XY compared to XX
1. Polyamine biosynthetic process (4 genes): Amd2, Azin1, Odc1, Srm
2. Nuclear pore (6 genes): Ipo7, Kpna1, Kpna2, Nup50, Nup88, Nup93
3. Purine ribonucleotide binding (31 genes): Abcf2, Atp2b1, Baz1b, Btaf1,
Cars, Cct2, Cct3, Cdk6, Ctps, Ddx21, Ddx3y, Dgkg, Eif2s3y, Eif4a1,
Gnai1, Gnl3, Hsp90ab1, Hspa4, Iars, Ide, Insr, Map2k3, Map3k6, Mat2a,
Psmc5, Rras2, Sar1a, Sgk1, Srp54a, Srp54b, Srp54c
4. tRNA binding (4 Genes): Cars, Mettl1, Xpo5, Yars
5. Nuclear lumen (16 genes) Ccnl2, Cfl2, Ddx21, Gnl3, Mbd1, Nop2, Nop56,
Polr2l, Pop4, Psmc5, Sfpq, Srp54a, Srp54b, Srp54c, Srp72, Srrt
6. Nucleolus (8 genes): Ddx21, Gnl3, Mbd1, Nop2, Nop56, Pop4, Srp72,
Wdr74
7. Transition metal ion binding (32 genes): Adamts1, Adamts9, B4galt4,
B4galt5, Baz1b, Cars, Dgkg, Dnaja2, Galnt11, Galnt7, Herc2, Iars, Ide,
Kdm5d, Klf13, Klf9, Luc7l, Mat2a, Mbd1, Mbnl2, Nr4a3, P4ha1, Polr2l,
Prnp, Sec23b, Slc30a1, Spire1, Sqstm1, Ubr2, Uty, Zdhhc14, Zfp597
8. Protein amino acid N-linked glycosylation (3 genes): Mgat2, Prkcsh, Stt3b
9. Extracellular matrix part (7 genes): Ccdc80, Col1a1, Col1a2, Col4a1,
Col5a2, Lamc1, Sparc
10. Immune response (7 genes): Ccl6, Ccl9, Cfb, Fcgr2b, Fcgr3, Il31ra, Tlr13
11. Acute inflammatory response (4 genes): Cd163, Cfb, Fcgr3, Stat3
12. Skin development (3 genes): Aars, Col1a1, Col5a2
13. Defense response (6 genes): Cd163, Cfb, Fcgr2b, Fcgr3, Stat3, Tlr13
14. Melanosome (3 genes): Pdia4, Pdia6, Snd1
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Table 3.3. (continued)
Upregulated in XX compared to XY
1. Ribosome (8 genes): Mrpl23, Mrpl52, Rpl18a, Rpl36, Rplp1, Rplp2,
Rps10, Ubc
2. DNA binding (20 genes): Arap1, Ddx3x, Ercc2, Foxd1, Gli1, Kcnip3,
Kdm5c, Msx1, Nr1h2, Nr3c2, Pold2, Polr2e, Polr2f, Relb, Sry, Stra13,
Thap3, Zfp395, Zfp593, Zfp687
3. Intracellular non-membrane-bounded organelle (18 genes): Arhgap6,
Camk2n1, Cdk5rap2, Eml2, Fgd1, Grm3, Homer3, Ifltd1, Myl6, Nudt16,
Pdlim2, Rpl13, Rpl35a, Rpl37a, Rps16, Sntg2, Ssh3, Ttf1
4. Positive regulation of macromolecule metabolic process (8 genes):
C1qtnf2, Jun, Pawr, Pax1, Pias3, Rarg, Six4, Ttf1
5. Postsynaptic density (3 genes): Camk2n1, Grm3, Homer3
6. Structural constituent of ribosome (4 genes): Rpl13, Rpl35a, Rpl37a,
Rps16
7. Death (6 genes): Dapk2, Pawr, Pdcd7, Serpinb9b, Spr, Traf2
8. Regulation of cell proliferation (6 genes): Ada, Jun, Pawr, Rarg, Six5,
Wnt2
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Table 3.4. Characteristics of XY and XX male Ldlr-/- mice infused with AngII.

Body weight (g)
Serum testosterone
(ng/ml)
Plasma Renin
Concentration (ng/ml)
Total serum
cholesterol (mg/dl)
Systolic blood
pressure (mmHg)
% Atherosclerotic
lesion in aortic arch

XY Sham

XY ORC

XX sham

XX ORC

28.6 ± 1

23.9 ± 0.6 **

31.3 ± 1

28.3 ± 0.8 **

1.77 ± 0.85

0.07 ± 0.02 **

1.53 ± 0.64

0.14 ± 0.02 **

0.37 ± 0.16

0.32 ± 0.09

0.25 ± 0.04

0.29 ± 0.05

1617 ± 242

1450 ± 320

1797 ± 140

1670 ± 115

132 ± 3

135 ± 4

119 ± 4 *

135 ± 3 **

21 ± 2

20 ± 3

19 ± 3

17 ± 2

Data are mean ± SEM from n = 920/group.
*, P<0.05 compared to XY within surgical treatment.
**, P<0.05 compared to sham within
genotype.
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Figure 3.1. Graphic depiction of experimental design for studies focused on the
formation (A) versus the progression (B) of AngII-induced AAAs.
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Figure 3.2. Sex chromosome complement, sex hormones, and an interaction
between these factors influence gene expression patterns in abdominal aortas of
XY and XX males. A, Total number of probe sets on arrays filtered to retain
transcripts with reliable signal intensity. B, Volcano plot illustrating fold change in
gene abundance (x-axis) and statistical significance (y-axis). Genes labelled in
blue exhibited significant increase in XY compared to XX abdominal aortas; genes
labeled in red exhibited significant increase in XX aortas. C, Frequency histogram
of the number of genes (y-axis) found at different p-values (x-axis). Chance is
illustrated by the dashed line. D, Biological pathway analysis (DAVID) of gene
expression comparing pathways upregulated in XY or XX abdominal aortas. Data
are mean ± SEM from n = 4-5 mice/genotype.
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Figure 3.3. RT-PCR analysis of mRNA abundance of key genes in abdominal
aortas from male XY and XX mice (sham, orchiectomized, ORC). A-C, mRNA
abundance of genes (A, Xist; B, Arntl; C, Npas2) exhibiting increased expression
in gene arrays from abdominal aortas of XY compared to XX male mice. D,E,
mRNA abundance of genes (D, Cyp2e1; E, Kap) exhibiting increased expression
in gene arrays from abdominal aortas of XY compared to XX male mice. Data are
mean ± SEM from n = 4-5 mice/group. *, P<0.05 compared to XY within surgical
group as defined by two-way ANOVA with genotype and surgery as between group
factors. **, P<0.05 compared to sham-operated within genotype as defined by
two-way ANOVA with surgery and genotype as between group factors and HolmSidak post hoc analysis.
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Figure 3.4. Pulse Wave Velocity (PWV) from male XY and XX Ldlr-/- mice. Data
are mean ± SEM from n = 6 mice/group. *, P<0.05 compared to XY as defined by
Student’s t-test.
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Figure 3.5. An XY sex chromosome complement mediates diffuse aortic vascular
disease, while an XX sex chromosome complement is associated with discrete
aneurysmal disease in abdominal aortas of male AngII-infused mice. A, Aortas
from XY and XX sham-operated males infused with AngII. B, Aorta weight
normalized to body weight. C, Area of the aortic arch. D, Incidence of thoracic
aortic aneurysms (%) in mice of each genotype and group. Data are mean ± SEM
from n = 10-13 mice/genotype/group who survived the 28 day protocol. *, P<0.05
compared to XY within sham-operated determined by two-way ANOVA with sham
and genotype as between group factors with Holm-Sidak post hoc analysis (B,C)
or by Fisher’s exact test (D). **, P<0.05 compared to sham-operated within
genotype determined by two-way ANOVA with sham and genotype as between
group factors with Holm-Sidak post hoc analysis.
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Figure 3.6. An XX sex chromosome complement results in focal AAA pathology of
increased size compared to XY males infused with AngII. A, Maximal AAA external
diameters. Symbols represent individual mice with lines representing mean ± SEM.
B, Internal diameters of abdominal aortas at selected intervals during infusion of
AngII. Data are mean ± SEM of mice surviving the 28 day infusions. C, AAA
incidence (percent above each bar). Numbers in boxes under each bar are mice
with an AAA/total number of mice per group. D, % Aneurysm rupture (percent
above each bar). *, P<0.05 compared to XY within sham-operated determined by
two-way ANOVA with Holm-Sidak post hoc analysis (A,B) or by Fisher’s exact test
(C,D). **, P<0.05 compared to sham-operated within genotype determined by twoway ANOVA with Holm-Sidak post hoc analysis (A,B) or by Fisher’s exact test
(C,D).
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Figure 3.7. Thoracic aortas from XY males, but not XX males, exhibit adventitial
thickening in response to AngII infusions. A, Representative thoracic aorta tissue
sections from XY and XX sham-operated and orchiectomized (ORC) males infused
with AngII for 28 days. Boxes are areas illustrated at higher magnification. B,
Quantification of the adventitial layer of thoracic aorta tissue sections from mice of
each group. C, Quantification of the medial layer of thoracic aorta tissue sections
from mice of each group. Data are mean ± from 6 tissue sections from n = 3
mice/group. *, P<0.05 compared to XY within treatment group determined by twoway ANOVA with surgery and genotype as between group factors, with HolmSidak post hoc analysis. **, P<0.05 compared to sham within genotype determined
by two-way ANOVA with surgery and genotype as between group factors, with
Holm-Sidak post hoc analysis. Scale bar represents 100 µm.
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Figure 3.8. mRNA abundance of key genes implicated in aneurysm development
in thoracic versus abdominal aortas from XY and XX male mice infused with either
saline or AngII-infused (1 day). A, Angiotensin converting enzyme (ACE) mRNA
abundance. B, Matrix metalloproteinase 2 mRNA abundance. C, Collagen 1a1
mRNA abundance. D, Thrombospondin 1 mRNA abundance. Data are mean ±
SEM from n = 5 mice/group/sex. *, P<0.05 compared to thoracic within genotype
determined by three-way ANOVA with region, treatment or genotype as between
group factors and Holm-Sidak post hoc analysis. **, P<0.05 compared to XY within
aortic region determined by three-way ANOVA with region, treatment or genotype
as between group factors and Holm-Sidak post hoc analysis. $, compared to saline
within region and genotype determined by three-way ANOVA with region,
treatment or genotype as between group factors and Holm-Sidak post hoc
analysis.
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Figure 3.9. XX males exhibit dilated AAAs while XY males exhibit diffuse aortic
disease with prolonged AngII infusions (3 months). A, Internal lumen diameters of
suprarenal aorta at selected intervals of AngII infusions. B, Maximal AAA external
diameters at study endpoint. Symbols represent individual mice with lines mean ±
SEM. C, Aortas from mice in each group at study endpoint. D, Aorta weight
normalized to body weight. E, Incidence of thoracic aortic aneurysms in mice of
each genotype. Data are mean ± SEM from n = 5-10 mice/group. *, P<0.05
compared to XY determined by Student t-test (A-D) or Fisher’s exact test (E).
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Figure 3.10. Ex vivo ultrasound analysis of AAAs from XY and XX male mice
infused with AngII for 3 months. A, Wall volume. B, Abdominal aortic lumen
volume.

C, Representative 3-D reconstructions of AAAs of mice from each

genotype. Data are mean ± n = 5 mice/group that survived the study protocol. *,
P<0.05 compared to XY as defined by Student’s t-test.
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CHAPTER IV. GENERAL DISCUSSION
4.1

Summary
The purpose of this study was to examine the role of sex chromosomes

versus sex hormones in mediating the sexual dimorphism of AngII-induced
abdominal aortic aneurysms (AAAs) in hypercholesterolemic female and male
mice.
First, we sought to examine the role of sex chromosomes in the absence
of male testosterone on gene expression patterns in abdominal aortas of
hypercholesterolemic female (non-infused) mice. We found that 88 genes were
expressed differentially in the abdominal aorta of XX versus XY females and the
presence of an XY sex chromosome complement in female mice increased the
expression of genes within inflammatory pathways in the abdominal region of the
aorta. These results suggest that sex chromosome regulation of inflammatory
gene expression patterns may play a role in development of AAAs.
Next, we investigated whether sex chromosomes regulate the
development of AngII-induced AAAs. Based on previous research demonstrating
that male AngII-infused mice have a higher AAA incidence than females
(Henriques TA, Huang et al. 2004), we hypothesized that the presence of an XY
sex chromosome complement in female mice promotes AngII-induced AAAs. Our
data suggest that the presence of an XY sex chromosome complement in female
mice does indeed increase the incidence and severity of AngII-induced AAAs.
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Previous studies demonstrated that the removal of androgen by castrating
male mice decreased the incidence and severity of AngII-induced AAAs and that
the administration of dihydrotestosterone (DHT) increased AAA formation in
female mice (Henriques TA, Zhang X et al. 2008). These results demonstrate
that both sex hormones (e.g., testosterone) and sex chromosome complement
(XY) contribute to sexual dimorphism of AngII-induced AAAs. To further examine
if androgen exerts similar effects to promote AAAs in XX versus XY females, we
androgenized the females of each genotype by giving them the same dose of
testosterone. The hypothesis was that administration of androgen would
augment the AAA formation both in XX and XY female mice. We administered
DHT to adult hypercholesterolemic XX and XY female mice before and
throughout AngII infusions. Although both XX and XY females exhibited a high
incidence of AAAs, XY females displayed increased mortality due to an
astonishingly high rate of aneurysm rupture.
Recent studies from our laboratory showed that a single dose of
testosterone to hypercholesterolemic neonatal female mice increased their
susceptibility to AngII-induced AAAs once they became adults (Zhang X et al.
2012). However, adult XX females that became susceptible to AAAs from early
life testosterone exposures had low circulating testosterone levels, suggesting
that testosterone exposures differentially influence AAA development depending
on sex chromosome complement. We therefore examined effects of neonatal
testosterone administration to XX and XY female mice on adult susceptibility to
AngII-induced AAAs. We administered testosterone to one-day old XX and XY
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females and infused them with AngII once they became adults to examine their
susceptibility to AAAs. Although there was no difference between XX and XY
females exposed to testosterone as neonates in AAA incidence, more than half
of the XY females died due to aneurysm rupture.
Next, we investigated the role of sex chromosomes in aortic aneurysm
pathology in the presence or absence of endogenous male testosterone by using
XX and XY hypercholesterolemic male mice. First, we examined the role of sex
chromosome complement on gene expression patterns of abdominal aortas from
male (non-infused) mice. We found 450 genes that were expressed differentially
in abdominal aortas of XY versus XX males. Analysis of gene pathways
determined these differential genes were involved in the extracellular matrix,
acute inflammatory response, cell proliferation regulation pathways, and the
immune response pathway. Further, we found that after 28 days of AngII
infusion, an XY sex chromosome complement in male mice induced diffuse
pathology along the entire length of the aorta while an XX sex chromosome
complement promoted restricted focal aneurysm pathology in the abdominal
region of the aorta. Moreover, XY males, but not XX males, infused with AngII
manifest thickening in the adventitial layer of the thoracic region of the aortas.
Additionally, we infused XY and XX males with saline or AngII for one day and
examined mRNA abundance of key genes involved in aortic pathology from the
abdominal and thoracic regions of the aorta. There were regional differences in
mRNA abundance of aneurysm-related genes between genotypes that were
potentiated with AngII. Finally, following prolonged infusion of AngII, males with
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an XY sex chromosome complement had diffuse AAAs with thickened aortic
walls, while males with an XX sex chromosome complement had discrete focal
AAA with a thinned wall aorta.
Overall, these studies support a role for sex chromosome complement in
the sexual dimorphism of AngII-induced AAA in hypercholesterolemic mice. An
XY sex chromosome complement promotes diffuse and severe aneurysm
pathology following AngII infusion while an XX sex chromosome complement
contributes to focal aneurysm pathology located to the suprarenal abdominal
aorta. Moreover, sex chromosome effects were associated with differences in
regional and AngII-induced abundance of mRNAs involved in AAA development
and progression.
4.2 Importance of studying the role of sex chromosomes in disease
There are many diseases that are sexually dimorphic. The National
Institutes of Health has recently stressed the significance of biological sex in
disease prevention and development, urging scientific researchers to include both
sexes, males and females, in the experimental design. Most studies examining sex
differences focus on the role of gonadal hormones. However, gonadal hormones do
not fully vindicate all sex differences.
Sex chromosome complement, in addition to gonadal hormones, may be a
primary mediator behind the sexual dimorphism of various chronic diseases. To
demonstrate the importance of sex chromosome effects, during the early stages
of embryo development, male and female pre-gonadal embryos are different in
size; XY embryos are larger and developmentally more advanced (Burgoyne PS,
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Thornhill AR et al. 1995; Burgoyne PS 1993). Additionally, even before gonadal
differentiation, the genes of male and female blastocysts are expressed
differentially (Bermejo-Alvarez P, Rizos D, Rath D et al. 2010). Moreover, the
phenomenon of X chromosome inactivation only partially occurs during the
preimplantation period (Bermejo-Alvarez P, Rizos D, Rath D et al. 2010), resulting
in upregulation of more than 80% of the X-linked genes in female embryos
(Bermejo-Alvarez P, Rizos D, Rath D et al. 2010).
In adult females, the presence of two X chromosomes can create genedosage differences when compared to males with only one X chromosome.
These gene-dosage differences is balanced by the process of X-inactivation, by
silencing the transcription of one of two X chromosomes in all cells (Okamoto I et
al. 2011; Penny GD et al. 1996; Payer B and Lee JT, 2008). However, some of
the genes on the X chromosome could escape the X-inactivation (Carrel L et al.
1999; Yang F et al. 2010). Although the Y chromosome is small and has less
genes than other chromosomes, genes within the male specific region of the Y
chromosomes have still been associated with several cardiovascular diseases
(Bloomer LD, Nelson CP et al. 2013).
4.3 AAA is a sexually dimorphic disease.
Male sex is one of the strongest risk factors for AAAs, with men exhibiting
four to ten fold higher prevalence than women (Weiss, Mahlmann et al. 2014;
Wilmink, Quick et al. 1998; Peumeekers, Hoes et al. 1994; Morris, Hubbard et al.
1994). Multiple studies from our laboratory and others have demonstrated that
male testosterone is a primary contributor to profound differences in susceptibility
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to AAAs between adult male versus female mice and rats (Henriques TA, Huang
et al. 2004; Henriques TA, Zhang X et al. 2008; Zhang X et al. 2012; Zhang X et
al. 2015; Cho BS Upchurch GR et al. 2009; Huang CK, Chang C et al. 2015;
Davis JP, Upchurch GR et al. 2016). However, it is unclear if testosterone by
itself is sufficient to explain the sexual dimorphism of AAAs. For example, our
laboratory has shown that a single dose of testosterone to neonatal female mice
was sufficient to make adult females susceptible to AngII-induced AAAs without
the need to see the testosterone for the whole life, which is needed in males
(Zhang X et al. 2012).
Additionally, multiple studies have shown that sex chromosomes may
contribute to sexual dimorphism of certain phenotypes and diseases (Robinson
DP, Huber SA et al. 2011; Ji H, Zheng W et al. 2010; Gioiosa L, Chen X et al.
2008; Chen X, Wang L et al. 2015; Li J, Chen X et al. 2014). Recent studies
have demonstrated that blood pressure responses to AngII infusion in mice
influenced by sex chromosome complement (Ji H, Zheng W et al. 2010).
Moreover, Turner’s Syndrome, or monosomy X in females, is associated with a
100-fold increase in risk of aortic dissection and rupture (Wong, Zacharin et al.
2014; Bondy CA 2008). Furthermore, several genes of the renin-angiotensinsystem are on the X chromosome, which suggest a possibility of gene dosage
effects for genes that escape X-inactivation.
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4.4 Mechanisms of sex chromosome effects on AAA
4.4.1 Role of sex chromosome complement on aortic gene expression
Our data indicate that the presence of an XY sex chromosome
complement in female mice without AngII infusion enhanced the expression of
genes involved in inflammatory pathways in the abdominal aorta, and this was
associated with increased oxidative stress and matrix metalloproteinase (MMP)
activity when the female mice were infused with AngII. Moreover, XY females
infused with AngII exhibited higher AAA incidence and the pathology was diffuse
and more severe. Additionally, administration of testosterone to XY females, in
order to mimic the male environment, resulted in an immense rate of aneurysmal
rupture.
Also as a part of this study, we decided to use intact male mice with an XY
or XX sex chromosome complement (meaning phenotypically male mice
exposed to testosterone throughout life). Without AngII infusion, there were 450
genes in the abdominal aorta that were influenced by sex chromosome
complement between XX and XY males. Analysis of gene array data using
DAVID pathway analysis revealed that these genes are involved in pathways that
might relate to the sex differences between males and females in susceptibility to
AAAs. Similar to our findings, other studies using the four core genotype mouse
model have shown that sex chromosomes influence gene expression in other
tissues like heart and the central nervous system (Du S, Itoh N et al. 2014; Li J,
Chen X et al. 2014). Interestingly, differences in gene expression due to sex
chromosome complement in the abdominal aorta were different in males
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compared to females (e.g., not the same genes and/or pathways were found in
XX females versus XX males). This may be explained either due to the difference
of sex hormones between males and females or due to the presence of the Sry
gene in males as previous studies have demonstrated that this gene regulates
blood pressure and gene expression of several components of the renin
angiotensin system in male rats (Ely D, Boehme S et al. 2011; Araujo FC,
Milsted A et al. 2015).
Of interest, from the gene microarray data, two clock genes, Arntl and
Npas2, were highly up-regulated in abdominal aortas from XX males compared
to XY males. Additionally, these genes were down regulated with castration, a
pattern that matches the AAA phenotype. Arntl, also known as Bmal1, is a
transcription factor that is part of the clock machinery. Arntl binds to E-box
promoters of Npas2, which regulates downstream clock genes like Pers and Cry
(Kristin Eckel-Mahan and Paolo Sassone-Corsi 2013). It is unclear if these genes
have protective or detrimental effects on AngII-induced AAAs. A recent study
suggested that Bmal1 in smooth muscle cells regulates the circadian rhythm of
blood pressure (Xie Z, Gong MC et al. 2015). Several studies have shown that
aortic smooth muscle cells undergo oscillation in the expression of clock genes
(McNamara P, Seo SB et al. 2001; Nonaka H, Emoto N et al. 2001). In our gene
expression studies, aortas harvested for the microarray were collected from the
mice in the morning between 9:30 am and 11:30 am and it is not known if the
expression of the clock genes are also different at other time points between XX
and XY mice. Further studies need to be conducted to confirm this. Currently,
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there is a dearth of publications about clock genes and aneurysms; however,
several studies have reported that aneurysm rupture and dissection demonstrate
a circadian pattern (Manfredini R, Portaluppi F et al. 1999; Manfredini R, Boari B
et al. 2004; Killeen S, Neary P et al. 2007; Vitale J, Manfredini R et al. 2015). As
AAA ruptures mostly peak in the morning, it has been suggested that the
morning high sympathetic activity could lead to increases in aortic shear stress
and rupture (Manfredini R, Boari B et al. 2004). By coincidence, even the king of
Great Britain, George II, who died in 1760 due to the first identified aortic rupture,
was reported to have died in the morning around 6 am (Leonard JC 1979).
4.4.2 Role of sex chromosomes on inflammation
AAA is a vascular disease that is characterized with inflammation. In our
study we found that XY females infused with AngII have a higher incidence and
more severe AAAs than XX females, and this was associated with increased
inflammatory responses. Specifically, XY females had increased gene
expression of interleukin-1β (IL-1β) and toll like receptor 8 in the abdominal aorta
as well as increased plasma concentrations of IL-1β when infused with AngII.
Also, abdominal aortas of XY females following AngII infusion had higher MMP-2
activity and oxidative stress. Similarly, XY males infused with AngII had diffuse
and more severe aneurysm pathology along the length of the aorta with higher
AngII-induced MMP2 mRNA abundance in thoracic aorta than XX males, which
may indicate that an XY sex chromosome complement promotes aortic pathology
by enhancing inflammatory responses to AngII.
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4.4.3 Role of sex chromosomes on the location of aortic pathology
Many studies, human and experimental, illustrated that males have a
higher prevalence of vascular diseases localized at different regions of the aorta
compared to females (Roman, Weinsaft et al. 2017; Olsson, Granath et al. 2006;
Lederle et al. 2001; Weiss et al. 2014; Wilmink et al. 1998; Peumeekers et al.
1994; Morris et al. 1994; Henriques TA et al. 2004; Henriques TA et al. 2008).
According to a study of more than 14,000 cases of thoracic aortic diseases in
Europe, the incidence of thoracic aortic aneurysm was doubled in men compared
to women (Olsson, Granath et al. 2006). Our results indicate that sex
chromosome complement has an important role in determining the location of the
AngII-induced pathology in the aorta. As mice with an XY sex chromosome
complement when infused with AngII developed diffuse pathology along the
aorta, while mice with an XX sex chromosome complement developed discrete
focal aneurysm only in the abdominal region of the aorta. In males, this
phenotype was mediated by both sex hormones and sex chromosome
complement as there was no difference between castrated XY and XX males,
this is in line with previous results from our laboratory demonstrating that
testosterone is needed in normal XY males to maintain high susceptibility to
AngII-induced AAAs (Henriques TA et al. 2004; Henriques TA et al. 2008; Zhang
X et al. 2012). It is unclear if these results relate to humans as the majority of
data from humans are derived from measurements of the intralumenal diameter
in the infrarenal region of the aorta. Our data raise the concern and urge the
need to perform multiple measurements along the length of the aorta.
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4.4.4 Role of sex chromosomes on aortic wall thickness
Interestingly, thoracic aortas from XY males infused with AngII have a
thicker adventitial layer than XX males. Also, XY males infused with AngII had
higher systolic blood pressures than XX males, which was not different between
sham and castrated groups in the XY males. Since the thoracic aortic aneurysm
incidence was reduced with castration, this suggests that blood pressure is not
the primary cause behind the development of diffuse aortic vascular pathologies
in XY males.
Differences in aortic wall thickness between XX and XY males may
suggest that males and females have differing levels of aortic components (e.g.,
muscle versus adventitia) within the aortic wall, and to our knowledge there is no
study that has made these types of comparisons. In fact, women with an AAA
have a poorer prognosis and AAAs rupture at smaller sizes (Grootenboer et al.
2009; Skibba et al. 2015; Sweeting et al. 2012; Thompson et al. 2013), which
could be due to a thin aortic wall because of lower expression of elastin and
collagen.
In this study, we found that XY males have higher expression of key genes
involved in aneurysm formation in the thoracic aorta while XX males have higher
expression in the abdominal aorta. It has been reported that different locations of
the aorta have different gene expression patterns (Pfaltzgraff ER, Shelton EL et
al. 2014). Furthermore, recently, it has been shown that different regions of the
aorta are populated by smooth muscle cells derived from diverse embryonic
origins (Sawada H, Daugherty A et al. 2017). This divergence could be the cause
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behind variance in the physiological and pathological reactions of the aorta
(Thieszen, Rosenquist et al. 1996; Majesky et al. 2007). In our study the
patterns of gene expression in abdominal versus thoracic aortas was enhanced
with only one day of AngII infusion. These differences in gene expression might
contribute to the diffuse versus focal vascular pathology observed between the
two genotypes, XX and XY.
Although women have lower risk of aortic aneurysms, paradoxically,
aneurysms progress more rapidly and tend to rupture at smaller sizes in women
(Cheung et al. 2017; Lo et al. 2014; Thompson et al. 2013; Sweeting et al. 2012;
Larsson et al. 2011; Mofidi et al. 2007; Solberg et al. 2005). In this study, we
found that XY males developed AAAs with thick aortic walls that continued to
expand with prolonged infusion of AngII. On the contrary, XX males developed
dilated AAAs that were restricted to the abdominal region of the aorta, and that
exhibited profound lumen dilation and thin walls with prolonged AngII infusion.
These results are in agreement with previous findings from our laboratory, which
showed that normal XY males with existing AngII-induced AAAs remodel to thin
walled AAAs after removal of endogenous androgen by castration (Zhang X et
al. 2015). This observed difference in wall thickness of AAAs between the two
sex chromosome complements, with thin walled AAAs in females may contribute
to increased aneurysm rupture (Cheung et al. 2017; Lo et al. 2014; Thompson et
al. 2013; Sweeting et al. 2012; Larsson et al. 2011; Mofidi et al. 2007; Solberg et
al. 2005).
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4.5 The interaction of sex chromosomes and sex hormones
4.5.1 The interaction of sex chromosomes and sex hormones in experimental
animals
Our laboratory previously demonstrated that androgen is a primary
mediator of AngII-induced AAAs (Henriques TA et al. 2004; Henriques TA et al.
2008; Zhang X et al. 2012; Zhang X et al. 2015). In this study we found that sex
chromosome complement has a prominent role to promote the formation and the
severity of AngII-induced AAAs as well. In females, unlike males, this role was
independent of gonadal hormones. XY females, either sham or ovariectomized,
had high AAA incidence, similar to the incidence of normal XY male mice.
However, male mice appear to continuously require the sex hormone,
testosterone, to maintain susceptibility to AngII-induced AAA, as AAA incidence
goes down to the level of females with orchiectomy (Henriques TA et al. 2004;
Henriques TA et al. 2008, Alsiraj Y et al. 2017).
The high AAA incidence of XY females could be due to a modest level of
testosterone, although this level was at least ten fold lower than that of normal
XY males. However, this level of testosterone in females, coupled with the
presence of the XY sex chromosome complement, might have a synergistic
effect and be detrimental enough to make the “weak” female aorta susceptible to
AAA, as it has been reported that female aortas have a lower capacity to absorb
force than male aortas (Ninomiya OH, Tavares Monteiro JA et al. 2015).
Additionally, our laboratory demonstrated previously that a single dose of
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testosterone to normal XX females when they are one-day old was sufficient to
permanently promote the formation of AAAs later in life (Zhang X et al. 2012).
Since testosterone is known to promote the susceptibility of AngII-induced AAAs
and the testosterone concentration was modestly higher in XY females, we
androgenized the two genotypes by exposing XX and XY female mice to the
same dose of androgen. This was done either by a single dose of testosterone
injected to one- day old neonates or by continuous diffusion of DHT for 6 weeks
through an implanted DHT tablet under the skin of adult XX and XY female mice.
Our results demonstrate that despite the high incidence of AAAs in both XX and
XY females, the administration of testosterone to female mice with an XY sex
chromosome complement increased the rate of aneurysm rupture to the highest
level that we have ever seen (73%).
This high level of AAA rupture in XY females is even higher than that of
XY males infused with AngII (Daugherty A et al. 2000; Henriques TA et al.
2004; Henriques TA et al. 2008). This may be due to the dose of testosterone
or the type of androgen used in these experiments, as DHT is the most potent
androgen and has an augmented effect compared to testosterone. Alternatively,
it may be due to the anatomical nature of the female aorta, as it has been
reported that there are sex differences in the size and the vessel biomechanical
properties between males and females. Male aortas are reported to be stronger
than female aortas, and have a higher failure load and failure tension than female
aortas (Ninomiya OH, Tavares Monteiro JA et al. 2015). Also, it has been shown
that female aortas have higher peak wall rupture risk than male aortas (Larsson
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E et al. 2011). Furthermore, women with AAAs are known to have poor prognosis
compared to males as their AAAs grow faster and rupture at a smaller size than
male AAAs (Grootenboer et al. 2009; Skibba et al. 2015; Sweeting et al. 2012;
Thompson et al. 2013). Thus, we conclude that putting male factors, namely XY
sex chromosome complement and testosterone, into females increased AAA
susceptibility and severity resulting in the AAAs of females to rupture at a very
high rate.
Conversely, in males, the XY sex chromosome complement required
testosterone to enhance the susceptibility to AngII-induced AAAs. We found that
XY males have diffuse aneurysm pathology in both thoracic and abdominal
aortas compared to XX males that have discrete focal abdominal aneurysms.
Notably, both XY and XX males lose their susceptibility to AngII-induced
pathology when castrated, which is in agreement with previous results
(Henriques TA et al. 2004; Henriques TA et al. 2008). The requirement of
testosterone in males to induce AngII-induced AAAs could be due to the
presence of the Sry gene in males, or due to early surges of testosterone levels
during fetal and neonatal life (Motelica-Heino I, Castanier M et al. 1988; Klinga
K, Bek E et al. 1978; Tomlinson C, Macintyre H et al. 2004). Early life
exposures to testosterone in males may have an organizational influence to
imprint the requirement for continuous testosterone exposures to maintain the
“activational effect” of testosterone in adults.
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4.5.2 The interaction of sex chromosomes and sex hormones in humans
In contrast to experimental AAA studies in animals, in which it is well
established that testosterone plays an important role in AAA formation and
progression, in humans this association is not so clear, with only one study
reporting that low testosterone levels were associated with AAA (Yeap et al.
2010). This group reported that serum total testosterone levels in men with an
AAA were 14.5 nmol/ liter compared to 15.5 nmol/ liter in men with no AAA, and
concluded that testosterone levels are negatively associated with the
development of AAA (Yeap BB, Hyde Z et al. 2010). In this study, there is only a
1 nmol/ liter difference in total testosterone level between non AAA and AAA
patients which does not necessarily indicate that low testosterone levels can
cause AAAs. In fact, the normal testosterone level in men ranges from 9-38
nmol/ liter (Fischbach FT, Dunning MB III, 2009 Manual of Laboratory and
Diagnostic Tests, 8th ed). This means that testosterone levels within this range
are sufficient to maintain the features of male sex, including the beneficial and
non-beneficial ones, and thus men with an AAA reported by Yeap et al most
likely had normal serum testosterone levels. Additionally, the reported
testosterone levels in these human studies were measured in men with an AAA.
Typically, AAAs are detected by ultrasound screening which is recommended for
men at or above the age of 65 (Mussa FF 2015). Thus, it is unclear if serum
testosterone levels were influenced before the formation of an AAA. Since the
testosterone level before or at the time of AAA formation is unknown, the
relationship between testosterone levels and AAA development are not clear.
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Possibly, the decline in testosterone levels of aging male AAA patients suggests
that sex chromosomes, either alone or in combination with sex hormones, may
contribute to the development and progression of AAAs. Previous data from our
laboratory show that a single dose of testosterone to female neonates was
enough to enhance the AAA susceptibility in adult female mice (Zhang X et al.
2012). In contrast to men, women tend to have an imbalance in their estrogen
to testosterone ratio after menopause (Dai W, Li Y et al. 2012; Rohr UD 2002),
which could explain, besides aging, why AAA incidences in women increase
(e.g., higher testosterone to estrogen ratio) with age with more propensity to
aneurysm rupture (Grootenboer et al. 2009; Skibba et al. 2015; Sweeting et al.
2012; Thompson et al. 2013).
4.6 Importance of including sex chromosomes in genome wide association
studies (GWAS)
Previous studies have suggested a genetic contribution to AAA
development, as people with a family history of AAA have a tenfold increased
chance of developing the disease (Johansen K and Koepsell T 1986). In an
Australian ultrasound screening study of siblings, AAA patients reported that 43%
of their siblings were males and were also diagnosed with having an AAA
(Frydman G, Walker PJ et al. 2003). Similarly, a small study in Sweden that
screened 108 siblings of AAA patients found that 16 of them with an AAA were
brothers (van der Lugt A, Kranendonk SE et al. 1992). Additionally, in a multinational study looking at familial aggregation of AAAs in families that have at
least two individuals with AAAs, 77% of the affected cases were males and most
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were brothers (Kuivaniemi H, Shibamura H et al. 2003). The high rate of disease
transmission between the male siblings suggests a Y chromosome influence in
transmission of the disease. However, our study is the first to provide direct
evidence of the role of sex chromosomes in the sexual dimorphism of AAA.
Sex chromosomes are usually neglected and not included in genome wide
association studies (GWAS) and these studies tend to focus only on autosomal
genes (Wise AL, Gyi L, Manolio TA 2013). This is usually due to technical
difficulties including statistical test selection, random X-inactivation, attribution,
and the phenomenon of escape from X-inactivation. The omission of sex
chromosomes from GWAS could overlook multiple genes on the sex
chromosomes that might contribute to the development and progression of
several diseases. Results from our studies, which support a role for sex
chromosomes in disease development, provide an impetus to include the sex
chromosomes in future GWAS analyses.
Taken together, our data indicate that sex chromosome complement
regulates aortic gene expression, responses to AngII and disease development,
with an XY sex chromosome complement increasing the incidence and the
rupture of diffuse aortic aneurysm pathology that progressed with thickened
aortic walls while an XX sex chromosome complement was associated with focal
AAA development that progressed with profound luminal dilation and thin aortic
walls. Effects of an XY sex chromosome complement were exacerbated by
testosterone administration, meaning there is a complex interaction between sex

140

chromosomes and gonadal hormones in regulating vascular diseases and
specifically AAAs.
4.7 Clinical Significance
It is important to understand the interplay between gonadal hormones and
sex chromosome genes, specifically pertaining to their role in the regulation of
the cardiovascular system. Our studies show that genes regulated by the sex
chromosome complement may affect vascular biology to enhance inflammation
and augment the response to AngII. Searching for the genes that are regulated
genes of sex chromosomes and which affect AAA development may uncover
sex-specific treatments for this and other AngII-related diseases.
The transgender population is on the rise, but studies on adverse effects
from the chronic use of sex hormone therapy on the opposite sex chromosome
complement are scarce. Of these, recent data suggest increased risk of
cardiovascular diseases in transgender women (Elamin et al. 2010). However,
the effect of chronic use of sex hormone therapy on the cardiovascular system in
transgender people has not been thoroughly investigated. In addition, the use of
sex hormone therapy for other reasons has also increased, specifically
androgen use to improve sex drive and to improve the performance ability in
elderly and in young males and females.
Our results suggest that sex chromosome complement influences aortic
disease development, with an XY sex chromosome complement having a large
influence in promoting aneurysm development and severity. These effects were
exacerbated when coupled with testosterone. Information from these studies
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should help in the future to develop sex specific therapies against aortic
aneurysms and other vascular diseases.
4.8 Future directions
Results from these studies demonstrate that the presence of an XY sex
chromosome complement in female mice was sufficient to increase the incidence
and the rupture rate of diffuse aortic aneurysm pathology, and that AAA
formation and severity were augmented by androgen treatment. Further, it was
found that XY males develop diffuse aortic disease along the entire length of the
aorta while XX males develop discrete focal aneurysm pathology in the
abdominal aorta. Moreover, XX and XY male mice exhibited regional differences
in aortic gene expression patterns that were also regulated by sex and AngII.
However, we did not address whether these effects were due to the presence of
the Y chromosome or due to the absence of the second X chromosome.
Therefore, a novel study should look to define whether genes on the Y
chromosome or gene dosage effects from the second X chromosome influence
the development and progression of AngII-induced vascular diseases. I suggest
use of the trisomy mouse model (Chen X, Williams-Burris SM et al. 2013), which
allows addition of a Y chromosome to an XX female, or an X chromosome to an
XY male. The trisomy model can be generated by mating a normal XY male to an
XY- female (this female is generated from the 4 core genotype mouse model).
According to Chen X et al. 2013, about 30% of the female offspring produced
from this breeding scheme would have XXY- sex chromosome complement.
XXY- females would then be mated to XY-(Sry+) males (this male is generated
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from the 4 core genotype mouse model) to produce offspring that have the
following genotypes, XX, XY, XXY, XYY phenotypic females that have ovaries
and XX, XY, XXY, XYY phenotypic males that have testes. By comparing XX
females to XXY females, or by comparing XY males to XXY males against AAA
will enable delineation of whether the presence of the Y chromosome or the
absence of the second X chromosome influences development and/or
progression of AngII-induced vascular diseases. If results from these studies
show that the X chromosome has a protective role against AngII-induced AAAs,
these findings then can be confirmed by the use of the XY* mouse model, a
model for Turner’s syndrome or monosomy X, a disease associated with high
risk of aortic dissection in females with one X chromosome (Wong, Zacharin et
al. 2014; Bondy CA 2008). This model produces mice with one X chromosome
or two X chromosomes, each in the absence or presence of a Y chromosome,
which will result in XX and XO females that have ovaries and XY and XXY males
that have testes (Burgoyne PS, Mahadevaiah SK et al. 1998). By studying the
AAA in XX versus XO females, this study will confirm the protective role of X
chromosome genes in aortic aneurysm, which could possibly open the door for
studies that search for the genes influenced by X chromosome genes that make
the monosomy X females predisposed to aortic pathologies, which can be tested
by looking for genes that are upregulated or downregulated by AngII in the
presence or absence of the second X chromosome. The XY* mouse model can
be created by mating XY* males to normal XX females. The XY* male is a male
mouse has a Y chromosome that has been re-arranged structurally. This Y
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chromosome has an aberrant pseudoautosomal region (PAR) that recombines
alternately with the PAR of the X chromosome during meiosis (Burgoyne PS,
Mahadevaiah SK et al. 1998).
Furthermore, after identifying the sex chromosome (X or Y) that has the
protective or the detrimental role in aortic aneurysm, we should move to define
the role of sex chromosomes (the detrimental or the protective ones) in
aneurysm progression as AAA is usually detected after it has been established
and progressed, due to ultrasound screening recommendations for men aged 65
to 75 years with a history of smoking (Hirsch AT, Haskal ZJ, Hertzer NR et al.
2006). The progression studies could be done by using the same mouse models
with prolonged AngII infusion and monitor the AAA progression by ultrasound.
The ultimate goals for these future studies are finding therapies that blunt the
progression of AAAs. Results from our studies indicate that sex chromosomes
determine differences in genes within the abdominal aorta that are either located
on the X chromosome and are known to escape X-inactivation, or are located on
the Y chromosome. These genes are either transcription or translation factors,
making them not easy to use as targetable therapy because they control a wide
range of genes on the autosomes. However, the autosomal genes that are
regulated by genes of the sex chromosomes could be used as potential
therapeutic targets. Furthermore, if we can identify genes that are influenced by
sex chromosomes, sex hormones, or by AngII in pivotal cell types, this will help
in developing a sex-specific therapy that could provide efficacy against the
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formation and/or progression of AngII-induced AAAs in male versus female mice
which could be applied to humans to blunt AAA progression and/ or rupture.
Another interesting future study should look at the role of clock genes,
specifically, Arntl and Npas2 in AngII-induced AAA. It would be of interest to look
to the expression of these genes in XX versus XY mice in different segments of
the aorta that are collected at different times of day, and based on the
information from this experiment, studies could be initiated that disrupt the
circadian rhythm to see its role in AngII-induced AAAs. Alternatively, we can
delete these genes from aortic smooth muscle cells and see their influence on
AngII-induced AAAs in males versus females.
4.9

Limitations of the study
First, we were unable to distinguish if the observed phenotype is due to

the presence of the Y chromosome or due to the absence of the second X
chromosome.
Second, XX males from the four core genotype model are sterile and have
small testes due to the absence of the Y chromosome which has genes that are
responsible for sperm production. Nonetheless, the levels of serum testosterone
were not statistically different between XX and XY males.
Third, XY females are transiently fertile and have a modestly higher level
of serum testosterone than XX females, but this level was at least ten fold lower
than the testosterone levels of normal males. Additionally, we normalized the
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testosterone level between XX and XY females by giving both genotypes the
same dose of androgen.
4.10

Concluding remarks
Findings of this dissertation demonstrate that sex chromosome

complement influences aortic gene expression as well as the development and
the severity of aortic aneurysmal diseases that form in response to AngII infusion
in hypercholesterolemic male and female mice. An XY sex chromosome
complement in phenotypic females was sufficient to promote the formation of
AngII-induced AAAs. Mimicking the male environment, testosterone exposure to
XY female mice increased the severity of AAAs by increasing the rupture rate to
up to 73%. Male mice with an XY sex chromosome complement developed
diffuse aortic aneurysms along the entire length of the aorta while XX males were
found to develop discrete focal aneurysm pathology restricted to the suprarenal
region of the aorta and both genotypes (XY and XX males) lost the susceptibility
to the disease after castration (Figure 4.1). These results demonstrate, for the
first time, that the sex chromosome complement has an immense impact on AAA
susceptibility, and that these effects are augmented by testosterone.
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Figure 4.1 Illustration of the role of sex chromosomes on AngII-induced AAA
susceptibility in mice. On the left, the large black arrow means a higher rate of
rupture in female XY mice compared to female XX mice. Basal aortic pictures
were adapted from Servier Medical Art.
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